dseol的个人主页 - 老虎社区

dseol

暂无个人介绍

IP属地：未知

1关注

0粉丝

0主题

0勋章

2021-06-16

Naise

抱歉，原内容已删除

2021-06-06

Naise

3 Technology Stocks You Can Buy and Hold for the Next Decade

2021-06-04

Naise

抱歉，原内容已删除

2021-06-03

to the moon!

抱歉，原内容已删除

2021-05-28

Naise

A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies

2021-05-28

Interesting

Snowflake Falls as Investors Weigh Higher Expenses Against Improved Outlook

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3584420887262369","uuid":"3584420887262369","gmtCreate":1621525361273,"gmtModify":1621525361273,"name":"dseol","pinyin":"dseol","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":160365949,"gmtCreate":1623772973681,"gmtModify":1634028472024,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160365949","repostId":"1123375053","repostType":4,"isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115359688,"gmtCreate":1622953042644,"gmtModify":1634096624055,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/115359688","repostId":"2140540596","repostType":4,"repost":{"id":"2140540596","pubTimestamp":1622820692,"share":"https://www.laohu8.com/m/news/2140540596?lang=&edition=full","pubTime":"2021-06-04 23:31","market":"us","language":"en","title":"3 Technology Stocks You Can Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2140540596","media":"Motley Fool","summary":"It can be tough to get married to stocks -- especially tech -- but here are three to leave alone for the long haul.","content":"<p>Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any profitable trade is technically a good trade. If you can get in and out at the right time, so be it.</p>\n<p>Thing is, there are plenty of tech names that are more than just flash-in-the-pan prospects, and are better suited for holding periods measured in years rather than weeks.</p>\n<p>Here's a closer look at three such technology companies. Not only will they be just as impressive 10 years from now as they are today, but their stocks should be trading at much higher prices.</p>\n<h2>Microsoft</h2>\n<p>It's tough to imagine a world without <b>Microsoft</b> (NASDAQ:MSFT). Its Windows operating system is installed on three-fourths of the world's desktops and laptops, according to GlobalStats, and its Office productivity software remains the gold standard for the category. <b>Sony</b>'s PlayStation gaming console enjoys more worldwide market share than Microsoft's Xbox, but the Xbox is closing the gap, and is still the most popular game console in the U.S.</p>\n<p>And these are things consumers can readily see. There's a whole different unseen array of Microsoft-made products that are doing similarly well. For instance, Canalys reports Microsoft's cloud computing business accounted for a second-best 19% of the world's first-quarter cloud infrastructure spending, and the company continues to close the gap with market-leader <b>Amazon</b>.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/362a8a5cb8d412d4e3895fa185d236b7\" tg-width=\"700\" tg-height=\"484\"><span>Image source: Getty Images.</span></p>\n<p>Now take a step back and ask a thoughtful, critical question: Is there any chance the world will have less need for computers, cloud computing, productivity software, or game consoles 10 years from now?</p>\n<p>Any reasonable and realistic answer has to be \"no.\" Indeed, it would be surprising if demand for these products and services wasn't considerably greater a decade from now. Being a market leader in multiple categories, Microsoft can steer the market's ongoing growth in a way that serves itself best. For example, the Windows operating system comes with trial versions of Office software pre-installed.</p>\n<p>Bolstering the bullish argument for long-term ownership of Microsoft is the company's evolving business model. Access to Azure, Office, and even video games can now be utilized on a monthly subscription basis, accessible via the cloud. This shift not only makes the company's products more affordable to begin using but also gives Microsoft a better chance of keeping those customers by making it easy to update and upgrade software.</p>\n<p>Last year, the last time Microsoft disclosed such data, it had already lined up more than $100 billion worth of subscription cloud revenue that had yet to be booked -- a figure that continues to edge upward.</p>\n<h2><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></h2>\n<p>Even after several high-profile cybersecurity gaffes embarrassed organizations ranging from <b>Target </b>to <b>Equifax</b> to Yahoo!, some of the world's most important companies are still being hacked. Most recently, Colonial Pipeline agreed to fork over $4.4 million to a computer hacking group known as Darkside to regain control of its 5,500 miles worth of refined oil pipelines.</p>\n<p>These things are preventable. They're just not being prevented, as too many organizations don't utilize all the digital defenses available to them. Perhaps the Colonial Pipeline debacle will encourage procurement of this protection.</p>\n<p>Enter <b>Palo Alto Networks</b> (NYSE:PANW). Simply put, Palo Alto offers software preventing unauthorized access to a company's network, internal apps, and data. It's even got a ransomware protection solution in its lineup that might have been able to save Colonial Pipeline a few million bucks.</p>\n<p>The opportunity is incredible, and should remain so for a while. P&amp;S Intelligence believes the cybersecurity market will grow at an average annual pace of 12.6%, from 2019's $120 billion to $434 billion by 2030. That's a lot, but it's only a fraction of the $10.5 trillion that Cybersecurity Ventures believes cybercrime will cost the world in 2025 alone if enterprises don't step up their digital defense games.</p>\n<p>Palo Alto is doing fine, logging more than seven consecutive years of rising revenue as more and more outfits build their digital moats. Given the outlook, more of the same kind of growth is in the cards for a while.</p>\n<h2>International Business Machines</h2>\n<p>Finally, add <b>International Business Machines</b> (NYSE:IBM) to your list of technology stocks to buy and hold for the next decade.</p>\n<p>Yes, this is the same IBM that failed to respond to the advent of things like cloud computing, mobile devices, and all that goes with both. The company's \"strategic imperatives\" plan unveiled in 2015 was meant to steer the company away from a legacy mainframe business that was already dying and toward more contemporary opportunities like the aforementioned cloud and mobile security. By and large, though, it was too little too late.</p>\n<p>The IBM of today, however, isn't the IBM from even as recently as two years ago. It's ready to compete where it counts.</p>\n<p>Take last month's revelation of new technologies capable of fabricating a 2-nanometer microchip as an example. The microscopic measure is in reference to how small a chip's transistors can be made and still function properly. The smaller, the better, as smaller transistors consume less power, operate faster, and require less space when room is a factor. For perspective, 7-nanometer chips are the best the market has to offer right now.</p>\n<p>It's not just more functional chips IBM is starting to develop, either. Just within the past few weeks, the company has unveiled a way for data centers to more efficiently store and retrieve data, and launched AutoSQL, which is capable of retrieving data eight times faster than previous approaches are. Both technologies have a myriad of potential uses, including in the artificial intelligence arena.</p>\n<p>Read between the lines. This isn't yesteryear's IBM.</p>\n<p>It could still take years for the company to fully monetize these and other breakthroughs, but they're worth the wait.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Technology Stocks You Can Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Technology Stocks You Can Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-04 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","IBM":"IBM","PANW":"Palo Alto Networks"},"source_url":"https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2140540596","content_text":"Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any profitable trade is technically a good trade. If you can get in and out at the right time, so be it.\nThing is, there are plenty of tech names that are more than just flash-in-the-pan prospects, and are better suited for holding periods measured in years rather than weeks.\nHere's a closer look at three such technology companies. Not only will they be just as impressive 10 years from now as they are today, but their stocks should be trading at much higher prices.\nMicrosoft\nIt's tough to imagine a world without Microsoft (NASDAQ:MSFT). Its Windows operating system is installed on three-fourths of the world's desktops and laptops, according to GlobalStats, and its Office productivity software remains the gold standard for the category. Sony's PlayStation gaming console enjoys more worldwide market share than Microsoft's Xbox, but the Xbox is closing the gap, and is still the most popular game console in the U.S.\nAnd these are things consumers can readily see. There's a whole different unseen array of Microsoft-made products that are doing similarly well. For instance, Canalys reports Microsoft's cloud computing business accounted for a second-best 19% of the world's first-quarter cloud infrastructure spending, and the company continues to close the gap with market-leader Amazon.\nImage source: Getty Images.\nNow take a step back and ask a thoughtful, critical question: Is there any chance the world will have less need for computers, cloud computing, productivity software, or game consoles 10 years from now?\nAny reasonable and realistic answer has to be \"no.\" Indeed, it would be surprising if demand for these products and services wasn't considerably greater a decade from now. Being a market leader in multiple categories, Microsoft can steer the market's ongoing growth in a way that serves itself best. For example, the Windows operating system comes with trial versions of Office software pre-installed.\nBolstering the bullish argument for long-term ownership of Microsoft is the company's evolving business model. Access to Azure, Office, and even video games can now be utilized on a monthly subscription basis, accessible via the cloud. This shift not only makes the company's products more affordable to begin using but also gives Microsoft a better chance of keeping those customers by making it easy to update and upgrade software.\nLast year, the last time Microsoft disclosed such data, it had already lined up more than $100 billion worth of subscription cloud revenue that had yet to be booked -- a figure that continues to edge upward.\nPalo Alto Networks\nEven after several high-profile cybersecurity gaffes embarrassed organizations ranging from Target to Equifax to Yahoo!, some of the world's most important companies are still being hacked. Most recently, Colonial Pipeline agreed to fork over $4.4 million to a computer hacking group known as Darkside to regain control of its 5,500 miles worth of refined oil pipelines.\nThese things are preventable. They're just not being prevented, as too many organizations don't utilize all the digital defenses available to them. Perhaps the Colonial Pipeline debacle will encourage procurement of this protection.\nEnter Palo Alto Networks (NYSE:PANW). Simply put, Palo Alto offers software preventing unauthorized access to a company's network, internal apps, and data. It's even got a ransomware protection solution in its lineup that might have been able to save Colonial Pipeline a few million bucks.\nThe opportunity is incredible, and should remain so for a while. P&S Intelligence believes the cybersecurity market will grow at an average annual pace of 12.6%, from 2019's $120 billion to $434 billion by 2030. That's a lot, but it's only a fraction of the $10.5 trillion that Cybersecurity Ventures believes cybercrime will cost the world in 2025 alone if enterprises don't step up their digital defense games.\nPalo Alto is doing fine, logging more than seven consecutive years of rising revenue as more and more outfits build their digital moats. Given the outlook, more of the same kind of growth is in the cards for a while.\nInternational Business Machines\nFinally, add International Business Machines (NYSE:IBM) to your list of technology stocks to buy and hold for the next decade.\nYes, this is the same IBM that failed to respond to the advent of things like cloud computing, mobile devices, and all that goes with both. The company's \"strategic imperatives\" plan unveiled in 2015 was meant to steer the company away from a legacy mainframe business that was already dying and toward more contemporary opportunities like the aforementioned cloud and mobile security. By and large, though, it was too little too late.\nThe IBM of today, however, isn't the IBM from even as recently as two years ago. It's ready to compete where it counts.\nTake last month's revelation of new technologies capable of fabricating a 2-nanometer microchip as an example. The microscopic measure is in reference to how small a chip's transistors can be made and still function properly. The smaller, the better, as smaller transistors consume less power, operate faster, and require less space when room is a factor. For perspective, 7-nanometer chips are the best the market has to offer right now.\nIt's not just more functional chips IBM is starting to develop, either. Just within the past few weeks, the company has unveiled a way for data centers to more efficiently store and retrieve data, and launched AutoSQL, which is capable of retrieving data eight times faster than previous approaches are. Both technologies have a myriad of potential uses, including in the artificial intelligence arena.\nRead between the lines. This isn't yesteryear's IBM.\nIt could still take years for the company to fully monetize these and other breakthroughs, but they're worth the wait.","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116257956,"gmtCreate":1622806974075,"gmtModify":1634097838262,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116257956","repostId":"1118016370","repostType":4,"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111185447,"gmtCreate":1622662677889,"gmtModify":1634099456961,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"to the moon!","listText":"to the moon!","text":"to the moon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/111185447","repostId":"1135947847","repostType":4,"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135355886,"gmtCreate":1622135151045,"gmtModify":1634183526830,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/135355886","repostId":"1175049399","repostType":4,"repost":{"id":"1175049399","pubTimestamp":1622127032,"share":"https://www.laohu8.com/m/news/1175049399?lang=&edition=full","pubTime":"2021-05-27 22:50","market":"us","language":"en","title":"A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=1175049399","media":"benzinga","summary":"As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a maj","content":"<p>As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.</p><p>Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.</p><p>Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.</p><p>Even though listing on a major exchange such as the NYSE and NASDAQ requires a company to comply with strict transparency and accountability rules, it also sends investors a sign that the company is serious about its business.</p><p>Benzinga has compiled a list of NYSE- and NASDAQ-listed cannabis companies, as well as a short description of the company's involvement in the sector. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business.</p><p>22nd Century Group, Inc. (NYSE:XXII)</p><p>This plant biotechnology company is mostly known for its workings in the tobacco industry, more precisely for its efforts to make smoking less unhealthy by minimizing the levels of nicotine in the tobacco plant. The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine.</p><p>22nd Century Group entered the cannabis space for the first time back in 2014 via a research collaboration with Anandia Labs, obtaining in that manner the U.S. right from Anandia to core patents covering the cannabinoid biosynthetic pathway in hemp/cannabis plants. Furthermore, the company got access to many new hemp-cannabis plant lines such as those with no THC, and those with higher levels of CBD or CBG, which are still part of its plant development pipeline. 22nd Century Group works on developing new hemp/cannabis plants with optimized and unique cannabinoid profiles and advantageous agronomic features.</p><p>The company said its most valuable current partnership covering the hemp/cannabis industry is with KeyGene, an<i>AgBiotech company</i>with a specialty in crop enhancement by molecular breeding.</p><p>Akerna Corp (NASDAQ:KERN)</p><p>Akerna was launched on June 17, 2019, following the merger of cannabis-focused blank check company MTech Acquisition Corp and MJ Freeway, a provider of seed-to-sale regulatory compliance technology and Enterprise Resource Planning platform.</p><p>Akerna is the first cannabis compliance technology company to be traded on NASDAQ and is the first NASDAQ-listed cannabis company led by a woman. The company allows cannabis businesses to connect data points in their supply chain making it more transparent and accountable.</p><p><b>Amyris (NASDAQ:AMRS)</b></p><p>Amyris is a science and technology company that creates and manufactures sustainable ingredients for various markets, such as Clean Health &amp; Beauty, and Flavors &amp; Fragrances. Its connection to the cannabis industry is through the research and production of biosynthetic cannabinoids, including CBG.</p><p><i>(*Note – the company hasinked a dealwith the biotech startup Lavvan to research and develop synthetic cannabinoids in 2019. Last September, Lavvansued the companyfor “wrongful use of Lavvan intellectual property in connection with their development, testing, and production of biosynthetic cannabinoids, including CBG.”)</i></p><p><b>Aphria Inc (NYSE:APHA)</b></p><p>Canadian medical marijuana producer Aphria became the first pure-play cannabis company to trade on the NYSE. The stock debuted on the major exchange on Nov. 2, 2018.</p><p>Prior to that, Aphria's stock had been listed on the over-the-counter market in the U.S. and on the Toronto Stock Exchange. Listing on the NYSE was a major step for Aphria, opening the company to a larger pool of investors.</p><p><b>Applied DNA Sciences Inc. (NASDAQ:APDN)</b></p><p>Applied DNA Sciences is a biotechnology company that provides molecular technologies that promote supply chain security, anti-counterfeiting and anti-theft technology. Last year, the companyentered a $5 million agreementwith a Canadian cannabis consultancy TheraCann International Benchmark to use the company’s “molecular tagging” technology in the cannabis industry. Last year, at an international cannabis conference in Panama, Applied DNA presented its new marijuana tracking technology.</p><p>Arena Pharmaceuticals (NASDAQ:ARNA)</p><p>Arena Pharmaceuticals is a biotech company located in San Diego, which has one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Other parts of its drug pipeline are focused on non-cannabinoid drugs. The core of its cannabis biotech operations is the research and development of its investigational drug candidate called Olorinab (APD371)<i>.</i>This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses.</p><p>Aurora Cannabis Inc (NYSE:ACB)</p><p>Canadian marijuana producer Aurora Cannabis is considered one of the best stocks for full exposure to the cannabis industry. Aurora is one of the largest cannabis companies in the world. It operates eight licensed production facilities, with&nbsp;five sales licenses and operations in 18 countries. The company has a funded production capacity of over 500,000 kilograms. Aurora recently acquired MedReleaf in a $2.5-billion merger, the industry’s largest.</p><p>Canopy Growth Corp (NYSE:CGC)</p><p>Canopy Growth is the largest marijuana company in the world by market capitalization. It’s also one of&nbsp;the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. It started the year with&nbsp;around 800,000 square feet, but recently it has said it reached a licensed platform of 4.3 million feet. Overall, Canopy has a production platform of 5.6 million feet, of which now 75 percent&nbsp;is licensed.</p><p>CannTrust Holdings Inc. (NYSE:CTST)</p><p><i><b>Delisted</b></i></p><p>On Feb. 25, CannTrust Holdings joined its peers on the New York Stock Exchange. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet. CannTrust has a 60,000 square-foot packaging facility in Vaughan, Ontario. Outside of Canada, CannTrust works with Cannatrek Ltd in Australia and has a joint venture with STENOCARE in Denmark.</p><p>Cara Therapeutics (NASDAQ:CARA)</p><p>Clinical-stage biotechnology company, Cara Therapeutics, is involved in the research and design of various chemical entities to help treat pain and itching, with most of them created to address opioid receptors. In previous years the company was examining the potential of CR-701, a synthetic cannabinoid receptor agonist for treating neuropathic pain and its ability to minimize hyperalgesia and allodynia.</p><p>cbdMD Inc (NYSE:YCBD)</p><p>cbdMD offers a range of CBD products, such as tinctures, oil, gummies, topicals and pet products. Recently, the company has partnered with a number of athletes, such as retired UFC champion Quinton “Rampage” Jackson and professional golfer Bubba Watson.</p><p>On May 1, cbdMD changed its name from Level Brands and the ticker from LEVB to YCBD following a vote from shareholders. It's the only CBD-focused U.S. company traded on a major exchange.</p><p><b>Coffee Holding Co., Inc. (NASDAQ:JVA)</b></p><p>A family-run coffee business that has been operating since 1971, providing a plethora of coffee products across the U.S. and Canada, Coffee Holdings joined the cannabis industry this year. In October, the companysigned binding agreementsto attain a 49% ownership of The Jordre Well, LLC, a cannabidiol beverage company, run by founders of Cannuka, a popular CBD skin brand. Under the deal, The Jordre Well will help Coffee Holding in the creation and commercialization of CBD-infused line extensions for the current coffee brands in the company’s portfolio.</p><p><b>Compass Diversified Holdings (NYSE</b>:CODI)</p><p>Compass Diversified Holdings is an investment and holdings company, concentrated on North American middle-market enterprises. It is run by Compass Group Management LLC, which has more than 20 years of experience in the field. Its interest in the cannabis industry is seen through its holdings of Manitoba Harvest and Hemp Oil Canada.</p><p>Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)</p><p>Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company concentrated on the development of new drugs to help with inflammatory and fibrotic illnessesby targeting the endocannabinoid system.Its principal drug candidate is called Lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. Furthermore, the company is working on creating a pipeline of drug candidates that address the endocannabinoid system.</p><p>Cronos Group Inc (NASDAQ:CRON)</p><p>In February, Cronos Group became the first pure-play cannabis stock to list on a major U.S. exchange. Based in Canada, Cronos is a vertically&nbsp;integrated cannabis company whose core business is medical marijuana, but it is also involved in the recreational space following the full legalization of weed in Canada earlier this month. Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. In addition, Cronos owns Peace Naturals and Original BC, which are licensed to grow and sell medical marijuana in Ontario and British Columbia, respectively.</p><p><b>Eastside Distilling, Inc. (NASDAQ:EAST)</b></p><p>Eastside Distilling, Inc. is a producer of award-winning craft spirits in Portland, Oregon, operating for 12 years. It is known for its specially designed product portfolio containing Burnside Bourbon, West End American Whiskey, Portland Potato Vodka, andHue-Hue Coffee Rum, among others.It is linked to the cannabis space through its ownership of Outlandish Beverages LLC, which manufactures and sells CBD-infused non-alcohol beverages.</p><p><b>Evogene (NASDAQ:EVGN)</b>Evogene is a Rehovot, Israel–headquartered computational biology company. It's also listed on Isreal’s Tel Aviv Stock Exchange under the ticker symbol “EVGN.”The company is involved in the creation of new products for life-science-based industries such as human health, agriculture and industrial applications. It has created a Computational Predictive Biology (CPB)&nbsp;platform, which enables computational design of microbes, small molecules and genes as key elements for life-science products. Its several subsidiaries rely on this platform for the development of various products, including medical cannabis (Canonic Ltd – subsidiary).FSD Pharma Inc. (NASDAQ:HUGE)</p><p>FSD Pharma is a biotech pharmaceutical research and development company that works on a pipeline of FDA-approved synthetic compounds directed at affecting the endocannabinoid system to help with various disorders of the central nervous system and autoimmune illnesses of the GI tract, skin, and the musculoskeletal system. Its subsidiary, FV Pharma, is a licensed producer under Canada’s Cannabis Act regulations with the license to grow cannabis in its facility in Cobourg, Ontario.</p><p>Greenlane Holdings, Inc. (NASDAQ:GNLN)</p><p>Greenlane went public on April 18. It's a Florida-based company that distributes over 140 brands of vaporizers and smoking accessories across the world through dispensaries, smoke shops, as well as through its e-commerce platforms.</p><p>The company doesn't provide any cannabis products, but it has major exposure to the industry and is betting big on its growth. Greenlane’s products are distributed across hundreds of licensed cannabis cultivators, processors&nbsp;and dispensaries.</p><p><b>GrowGeneration Corp. (NASDAQ:GRWG)</b></p><p>GroGeneration Corp. is a Denver-based hydroponics innovator and a distributor of agricultural products that also serves U.S. cannabis companies. It runs retail hydroponic and organic specialty gardening retail stores, providing plant nutrition, advanced lighting technology, and farming soils, among others. GrowGeneration recently announced the completion of its acquisition of California-based GrowBiz, one of the largest hydroponic garden centers in the U.S.6</p><p>GW Pharmaceuticals PLC (NASDAQ:GWPH)</p><p>Among pharmaceutical companies, UK-based GW Pharmaceutical is the closest to being a pure-play cannabis company.</p><p>GW is focused on developing cannabis-based drugs. Its Sativex drug, for the treatment of multiple sclerosis, was the first-ever natural cannabis plant derivative to be approved by regulators in any country, receiving UK approval in 2010. Earlier this year, Epidiolex, for the treatment of epilepsy, became the first cannabis-derived drug to bag FDA approval.</p><p>HEXO Corp (NYSE:HEXO)</p><p>Hexo is a Gatineau, Quebec-based adult-use cannabis company that focuses on innovative, smoke-free and traditional cannabis products. The company was previously known as Hydropothecary Corp, but changed its name to HEXO in August 2018 following the launch of the HEXO brand for the adult-use market (medical products retained the Hydropothecary brand).</p><p>In August 2018, HEXO and<b>Molson Coors Brewing Co</b>(NYSE:TAP)’s Canadian division agreed to form a joint venture (later revealed as Truss) to develop non-alcoholic, cannabis-infused beverages for the Canadian market. HEXO’s stock debuted on the NYSE American on Jan. 23.</p><p>India Globalization Capital, Inc. (NYSEAMERICAN: IGC)</p><p>India Globalization Capital is a Maryland-based company with two lines of operations – infrastructure, and cannabinoid-based products. Its cannabis-based products are designed to help with pain, seizures, post-traumatic stress disorder, and various other ailments.The company offers patent-pending products that provide micro-doses of cannabinoids mixed with other natural components.</p><p>Innovative Industrial Properties Inc (NYSE:IIPR)</p><p>Innovative Industrial Properties is the only publicly traded cannabis-focused Real Estate Investment Trust. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U.S. Among its lessees are PharmaCann (New York and Massachusetts), The Pharm (Arizona), Holistic Industries (Maryland and Massachusetts), Green Peak (Michigan) and Vireo Health (Minnesota, New York, and Pennsylvania).</p><p>Intec Pharma Ltd. (NASDAQ:NTEC)</p><p>Intec Pharma is a biopharmaceutical company that works on creating a variety of therapeutics relying on its proprietary According Pill technology. Among, the company’s product pipeline candidates in clinical development are AP-cannabinoids. They are being examined for helping with various conditions such as cancer pain and opioid-sparing pain, by delivering one or both of the main cannabinoids naturally found in Cannabis sativa, CBD and THC.</p><p><b>Marrone Bio Innovations, Inc. (NASDAQ:MBII)</b></p><p>Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for various markets, such as agriculture and water treatment. The company’s three active ingredients are legalized for use on cannabis crops in California.</p><p><b>Neptune Wellness Solutions Inc.(NASDAQ:NEPT)</b></p><p>Neptune Wellness Solutions Inc. is a diversified wellness company. Through its 9354-7537 Quebec Inc., Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its facility in Quebec. It is known for its proprietary recreational product line that includes High CBD Oil, High CBD Capsules, Classic Hashish, and Legacy Hashish.</p><p>NEWAGE (NASDAQ:NBEV)</p><p>NewAge is a Colorado-based omnichannel company that tries to motivate consumers to “live healthy.” It is the only one-stop shop of healthy beverages, with famous brands such as Nestea, Evian, Búcha Live Kombucha, Illy Coffee, and Volvic. Recently the company has announced that its Noni+CBD product has obtained sales approval by the Japanese Ministry of Health and the Japanese Narcotics Control Division. The company also offers a portfolio of hemp products, such as oils, body creams, and roll-on gels, which has reached Australia and New Zealand.</p><p><b>NIC Inc. (NASDAQ:EGOV)</b></p><p>The Olathe, Kansas-based provider of digital government services, NIC Inc. has reached the cannabis space through the acquisition of Complia, a Denver-based technology platform for regulating cannabis and hemp industries.</p><p><b>OrganiGram Holdings Inc (NASDAQ:OGI)</b></p><p>After announcing it had applied to list its stock on NASDAQ on April 26, it took slightly more than two weeks for the Canadian cannabis producer to get approved and another week for it to start trading on May 21.</p><p>OrganiGram produces indoor-grown medical and adult-use cannabis in Canada and has distribution across all 10 provinces. The company’s plants for recreational use have recently received organic certification from the Pro-Cert Organic Systems Ltd. In anticipation of the legalization of edibles in Canada later this year, OrganiGram has invested $15 million into an automated production line for cannabis-infused chocolate that has a capacity of 4.0 million kilograms per year, which will be delivered this fall.</p><p>Pyxus International Inc (NYSE:PYX)</p><p><b><i>Delisted</i></b></p><p>Until recently, Pyxus International was known as Alliance One International and was involved in tobacco growing and packaging. Earlier this year, the company rebranded into Pyxus as it embraced&nbsp;cannabis. In January, Pyxus’s subsidiary Canadian Cultivated Products acquired 75 percent&nbsp;of Canada’s Island Garden and 80 percent&nbsp;of Goldleaf Pharm. Later, Canadian Cultivated Products was rebranded into FIGR Cannabis.</p><p>At the beginning of October, Goldleaf received a cultivation license from Health Canada. In addition, Canada’s Island Garden has received a license to sell marijuana and signed an agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products. Moreover, Pyxus International’s Korent subsidiary is involved in the production of industrial hemp and hemp-derived CBD oil and liquid for e-cigarettes.</p><p>Sundial Growers Inc. (NASDAQ:SNDL)</p><p>Alberta-based cannabis company, Sundial Growers is known for cultivating a specific range of cannabis strains. It has established cannabis brands to Heal, Help and Play, with Heal symbolizing cannabis products consumed as prescribed medical therapies, Help products that support overall health and wellbeing via CBD, and Play that includes products for empowering social and spiritual occasions. The company runs two locations in Alberta, but it has announced plans to expand to British Columbia by building a new facility.</p><p>Therapix Biosciences Ltd (NASDAQ:TRPX)</p><p><b><i>Delisted</i></b></p><p>Israel-based Therapix Biosciences is involved in developing a pipeline of drugs based on the FDA-approved cannabinoid Dronabinol, such as THX-110 for the treatment of Tourette syndrome and obstructive sleep apnea, THX-130 for mild cognitive impairments&nbsp;and THX-150 for the treatment of infectious diseases. Recently, Canadian marijuana producer<b>FSD Pharma</b>(OTC:FSDDF) announced that it would acquire Therapix Biosciences for $48 million in stock.</p><p>Tilray Inc (NASDAQ:TLRY)</p><p>In July 2018, Tilray became the first pure-play cannabis company to list on NASDAQ, and its stock quickly captured attention as it surged eightfold in just two months after the IPO.</p><p>The company was founded in 2013, and in 2016 it became the first medical marijuana producer in North America to receive a good manufacturing practices certification. Tilray’s production capacity currently lags behind giants like Aurora or Canopy Growth at around 15,000 kilograms. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year.</p><p><b>Urban-gro, Inc.</b>&nbsp;(NASDAQ:UGRO)</p><p>An engineering company, urban-gro is primarily focused on the popular horticulture market. It offers integration and design services of advanced environmental equipment systems into high-performance facilities. It has already operated in hundreds of Controlled Environment Agriculture (CEA)&nbsp;facilities.</p><p>With its crop-agnostic solutions, it reaches the cannabis CEA sphere. The company provides “turn-key commercial cannabis grow room design services and solutions” to help its clients attain their goals working in sync with the environment, plants, and people. &nbsp;Cannabis grow room designs can be carefully crafted to meet various regulatory demands, including energy efficiency goals, Good Agricultural Practices, and/or Good Manufacturing Practice certification.</p><p>It also offers its gro-care managed services platform that aims to help with facility optimization. &nbsp;With its services, urban-gro pushes building performances to another level.</p><p>Village Farms International, Inc.&nbsp; (NASDAQ:VFF)</p><p>Village Farms International is a vertically integrated greenhouse grower and the only publicly traded greenhouse business in Canada. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. The company is connected to the cannabis industry via its majority ownership position in Pure Sunfarms, a Canada-based cannabis growing operations. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U.S hemp-derived CBD market, already having two joint ventures – Village Fields Hemp USA, LLC and Arkansas Valley Green and Gold Hemp LLC.</p><p>Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)</p><p>Zynerba Pharmaceuticals is focused on developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric diseases. Among its product candidates is ZYN002 CBD for children and adolescents with Fragile X syndrome, a genetic condition that causes intellectual disability, behavioral and learning challenges and is the most commonly known single-gene cause of autism spectrum disorder. Other targeted conditions include developmental and epileptic encephalopathies and adult epilepsy.</p><p>Non-Cannabis Companies With Interests In The SpaceAbbVie, Inc. (NYSE:ABBV)</p><p>This biopharmaceutical company works on creating solutions to help treat various health conditions, from those life-threatening diseases to other chronic disorders. Its core focus is on four therapeutic fields – oncology, neurosciences, virology, and immunology. Its main connection to the cannabis industry lies in its drug, called Marinol, or Dronabinol, which is created of a synthetic form of marijuana. Marinol is used to help with nausea and vomiting caused by chemotherapy, and also to treat the loss of appetite in patients suffering from AIDS.</p><p>Altria Group, Inc. (NYSE:MO)</p><p>Altria Group is known as one of the biggest manufacturers and advertisers of tobacco, cigarettes and similar products in the world. While it runs its operations across the world, its main headquarters are located in Virgina, outside of the city of Richmond. Its connection to the cannabis sector is through its considerable stake in a Canada-based pure-play cannabis stock Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).</p><p>Scotts Miracle-Gro Company (NYSE:SMG)</p><p>This is a company that produces and sells consumer lawn, garden and pest control products, but some websites consider it a cannabis stock, only because its products can be used in the cannabis industry. In its 2019 Annual Report, the company also states under the ‘risks’ section that end user may buy their products to cultivate cannabis. “Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end-users who may grow any variety of plants, including cannabis.”</p><p>Psychemedics Corporation (NASDAQ:PMD)</p><p>This is a provider of hair testing services for the detection of drugs of abuse, offering marijuana hair drug tests as well.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Complete List Of NYSE And NASDAQ-Listed Cannabis Companies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-27 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.Given the ...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175049399","content_text":"As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.Even though listing on a major exchange such as the NYSE and NASDAQ requires a company to comply with strict transparency and accountability rules, it also sends investors a sign that the company is serious about its business.Benzinga has compiled a list of NYSE- and NASDAQ-listed cannabis companies, as well as a short description of the company's involvement in the sector. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business.22nd Century Group, Inc. (NYSE:XXII)This plant biotechnology company is mostly known for its workings in the tobacco industry, more precisely for its efforts to make smoking less unhealthy by minimizing the levels of nicotine in the tobacco plant. The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine.22nd Century Group entered the cannabis space for the first time back in 2014 via a research collaboration with Anandia Labs, obtaining in that manner the U.S. right from Anandia to core patents covering the cannabinoid biosynthetic pathway in hemp/cannabis plants. Furthermore, the company got access to many new hemp-cannabis plant lines such as those with no THC, and those with higher levels of CBD or CBG, which are still part of its plant development pipeline. 22nd Century Group works on developing new hemp/cannabis plants with optimized and unique cannabinoid profiles and advantageous agronomic features.The company said its most valuable current partnership covering the hemp/cannabis industry is with KeyGene, anAgBiotech companywith a specialty in crop enhancement by molecular breeding.Akerna Corp (NASDAQ:KERN)Akerna was launched on June 17, 2019, following the merger of cannabis-focused blank check company MTech Acquisition Corp and MJ Freeway, a provider of seed-to-sale regulatory compliance technology and Enterprise Resource Planning platform.Akerna is the first cannabis compliance technology company to be traded on NASDAQ and is the first NASDAQ-listed cannabis company led by a woman. The company allows cannabis businesses to connect data points in their supply chain making it more transparent and accountable.Amyris (NASDAQ:AMRS)Amyris is a science and technology company that creates and manufactures sustainable ingredients for various markets, such as Clean Health & Beauty, and Flavors & Fragrances. Its connection to the cannabis industry is through the research and production of biosynthetic cannabinoids, including CBG.(*Note – the company hasinked a dealwith the biotech startup Lavvan to research and develop synthetic cannabinoids in 2019. Last September, Lavvansued the companyfor “wrongful use of Lavvan intellectual property in connection with their development, testing, and production of biosynthetic cannabinoids, including CBG.”)Aphria Inc (NYSE:APHA)Canadian medical marijuana producer Aphria became the first pure-play cannabis company to trade on the NYSE. The stock debuted on the major exchange on Nov. 2, 2018.Prior to that, Aphria's stock had been listed on the over-the-counter market in the U.S. and on the Toronto Stock Exchange. Listing on the NYSE was a major step for Aphria, opening the company to a larger pool of investors.Applied DNA Sciences Inc. (NASDAQ:APDN)Applied DNA Sciences is a biotechnology company that provides molecular technologies that promote supply chain security, anti-counterfeiting and anti-theft technology. Last year, the companyentered a $5 million agreementwith a Canadian cannabis consultancy TheraCann International Benchmark to use the company’s “molecular tagging” technology in the cannabis industry. Last year, at an international cannabis conference in Panama, Applied DNA presented its new marijuana tracking technology.Arena Pharmaceuticals (NASDAQ:ARNA)Arena Pharmaceuticals is a biotech company located in San Diego, which has one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Other parts of its drug pipeline are focused on non-cannabinoid drugs. The core of its cannabis biotech operations is the research and development of its investigational drug candidate called Olorinab (APD371).This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses.Aurora Cannabis Inc (NYSE:ACB)Canadian marijuana producer Aurora Cannabis is considered one of the best stocks for full exposure to the cannabis industry. Aurora is one of the largest cannabis companies in the world. It operates eight licensed production facilities, with five sales licenses and operations in 18 countries. The company has a funded production capacity of over 500,000 kilograms. Aurora recently acquired MedReleaf in a $2.5-billion merger, the industry’s largest.Canopy Growth Corp (NYSE:CGC)Canopy Growth is the largest marijuana company in the world by market capitalization. It’s also one of the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. It started the year with around 800,000 square feet, but recently it has said it reached a licensed platform of 4.3 million feet. Overall, Canopy has a production platform of 5.6 million feet, of which now 75 percent is licensed.CannTrust Holdings Inc. (NYSE:CTST)DelistedOn Feb. 25, CannTrust Holdings joined its peers on the New York Stock Exchange. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet. CannTrust has a 60,000 square-foot packaging facility in Vaughan, Ontario. Outside of Canada, CannTrust works with Cannatrek Ltd in Australia and has a joint venture with STENOCARE in Denmark.Cara Therapeutics (NASDAQ:CARA)Clinical-stage biotechnology company, Cara Therapeutics, is involved in the research and design of various chemical entities to help treat pain and itching, with most of them created to address opioid receptors. In previous years the company was examining the potential of CR-701, a synthetic cannabinoid receptor agonist for treating neuropathic pain and its ability to minimize hyperalgesia and allodynia.cbdMD Inc (NYSE:YCBD)cbdMD offers a range of CBD products, such as tinctures, oil, gummies, topicals and pet products. Recently, the company has partnered with a number of athletes, such as retired UFC champion Quinton “Rampage” Jackson and professional golfer Bubba Watson.On May 1, cbdMD changed its name from Level Brands and the ticker from LEVB to YCBD following a vote from shareholders. It's the only CBD-focused U.S. company traded on a major exchange.Coffee Holding Co., Inc. (NASDAQ:JVA)A family-run coffee business that has been operating since 1971, providing a plethora of coffee products across the U.S. and Canada, Coffee Holdings joined the cannabis industry this year. In October, the companysigned binding agreementsto attain a 49% ownership of The Jordre Well, LLC, a cannabidiol beverage company, run by founders of Cannuka, a popular CBD skin brand. Under the deal, The Jordre Well will help Coffee Holding in the creation and commercialization of CBD-infused line extensions for the current coffee brands in the company’s portfolio.Compass Diversified Holdings (NYSE:CODI)Compass Diversified Holdings is an investment and holdings company, concentrated on North American middle-market enterprises. It is run by Compass Group Management LLC, which has more than 20 years of experience in the field. Its interest in the cannabis industry is seen through its holdings of Manitoba Harvest and Hemp Oil Canada.Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company concentrated on the development of new drugs to help with inflammatory and fibrotic illnessesby targeting the endocannabinoid system.Its principal drug candidate is called Lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. Furthermore, the company is working on creating a pipeline of drug candidates that address the endocannabinoid system.Cronos Group Inc (NASDAQ:CRON)In February, Cronos Group became the first pure-play cannabis stock to list on a major U.S. exchange. Based in Canada, Cronos is a vertically integrated cannabis company whose core business is medical marijuana, but it is also involved in the recreational space following the full legalization of weed in Canada earlier this month. Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. In addition, Cronos owns Peace Naturals and Original BC, which are licensed to grow and sell medical marijuana in Ontario and British Columbia, respectively.Eastside Distilling, Inc. (NASDAQ:EAST)Eastside Distilling, Inc. is a producer of award-winning craft spirits in Portland, Oregon, operating for 12 years. It is known for its specially designed product portfolio containing Burnside Bourbon, West End American Whiskey, Portland Potato Vodka, andHue-Hue Coffee Rum, among others.It is linked to the cannabis space through its ownership of Outlandish Beverages LLC, which manufactures and sells CBD-infused non-alcohol beverages.Evogene (NASDAQ:EVGN)Evogene is a Rehovot, Israel–headquartered computational biology company. It's also listed on Isreal’s Tel Aviv Stock Exchange under the ticker symbol “EVGN.”The company is involved in the creation of new products for life-science-based industries such as human health, agriculture and industrial applications. It has created a Computational Predictive Biology (CPB) platform, which enables computational design of microbes, small molecules and genes as key elements for life-science products. Its several subsidiaries rely on this platform for the development of various products, including medical cannabis (Canonic Ltd – subsidiary).FSD Pharma Inc. (NASDAQ:HUGE)FSD Pharma is a biotech pharmaceutical research and development company that works on a pipeline of FDA-approved synthetic compounds directed at affecting the endocannabinoid system to help with various disorders of the central nervous system and autoimmune illnesses of the GI tract, skin, and the musculoskeletal system. Its subsidiary, FV Pharma, is a licensed producer under Canada’s Cannabis Act regulations with the license to grow cannabis in its facility in Cobourg, Ontario.Greenlane Holdings, Inc. (NASDAQ:GNLN)Greenlane went public on April 18. It's a Florida-based company that distributes over 140 brands of vaporizers and smoking accessories across the world through dispensaries, smoke shops, as well as through its e-commerce platforms.The company doesn't provide any cannabis products, but it has major exposure to the industry and is betting big on its growth. Greenlane’s products are distributed across hundreds of licensed cannabis cultivators, processors and dispensaries.GrowGeneration Corp. (NASDAQ:GRWG)GroGeneration Corp. is a Denver-based hydroponics innovator and a distributor of agricultural products that also serves U.S. cannabis companies. It runs retail hydroponic and organic specialty gardening retail stores, providing plant nutrition, advanced lighting technology, and farming soils, among others. GrowGeneration recently announced the completion of its acquisition of California-based GrowBiz, one of the largest hydroponic garden centers in the U.S.6GW Pharmaceuticals PLC (NASDAQ:GWPH)Among pharmaceutical companies, UK-based GW Pharmaceutical is the closest to being a pure-play cannabis company.GW is focused on developing cannabis-based drugs. Its Sativex drug, for the treatment of multiple sclerosis, was the first-ever natural cannabis plant derivative to be approved by regulators in any country, receiving UK approval in 2010. Earlier this year, Epidiolex, for the treatment of epilepsy, became the first cannabis-derived drug to bag FDA approval.HEXO Corp (NYSE:HEXO)Hexo is a Gatineau, Quebec-based adult-use cannabis company that focuses on innovative, smoke-free and traditional cannabis products. The company was previously known as Hydropothecary Corp, but changed its name to HEXO in August 2018 following the launch of the HEXO brand for the adult-use market (medical products retained the Hydropothecary brand).In August 2018, HEXO andMolson Coors Brewing Co(NYSE:TAP)’s Canadian division agreed to form a joint venture (later revealed as Truss) to develop non-alcoholic, cannabis-infused beverages for the Canadian market. HEXO’s stock debuted on the NYSE American on Jan. 23.India Globalization Capital, Inc. (NYSEAMERICAN: IGC)India Globalization Capital is a Maryland-based company with two lines of operations – infrastructure, and cannabinoid-based products. Its cannabis-based products are designed to help with pain, seizures, post-traumatic stress disorder, and various other ailments.The company offers patent-pending products that provide micro-doses of cannabinoids mixed with other natural components.Innovative Industrial Properties Inc (NYSE:IIPR)Innovative Industrial Properties is the only publicly traded cannabis-focused Real Estate Investment Trust. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U.S. Among its lessees are PharmaCann (New York and Massachusetts), The Pharm (Arizona), Holistic Industries (Maryland and Massachusetts), Green Peak (Michigan) and Vireo Health (Minnesota, New York, and Pennsylvania).Intec Pharma Ltd. (NASDAQ:NTEC)Intec Pharma is a biopharmaceutical company that works on creating a variety of therapeutics relying on its proprietary According Pill technology. Among, the company’s product pipeline candidates in clinical development are AP-cannabinoids. They are being examined for helping with various conditions such as cancer pain and opioid-sparing pain, by delivering one or both of the main cannabinoids naturally found in Cannabis sativa, CBD and THC.Marrone Bio Innovations, Inc. (NASDAQ:MBII)Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for various markets, such as agriculture and water treatment. The company’s three active ingredients are legalized for use on cannabis crops in California.Neptune Wellness Solutions Inc.(NASDAQ:NEPT)Neptune Wellness Solutions Inc. is a diversified wellness company. Through its 9354-7537 Quebec Inc., Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its facility in Quebec. It is known for its proprietary recreational product line that includes High CBD Oil, High CBD Capsules, Classic Hashish, and Legacy Hashish.NEWAGE (NASDAQ:NBEV)NewAge is a Colorado-based omnichannel company that tries to motivate consumers to “live healthy.” It is the only one-stop shop of healthy beverages, with famous brands such as Nestea, Evian, Búcha Live Kombucha, Illy Coffee, and Volvic. Recently the company has announced that its Noni+CBD product has obtained sales approval by the Japanese Ministry of Health and the Japanese Narcotics Control Division. The company also offers a portfolio of hemp products, such as oils, body creams, and roll-on gels, which has reached Australia and New Zealand.NIC Inc. (NASDAQ:EGOV)The Olathe, Kansas-based provider of digital government services, NIC Inc. has reached the cannabis space through the acquisition of Complia, a Denver-based technology platform for regulating cannabis and hemp industries.OrganiGram Holdings Inc (NASDAQ:OGI)After announcing it had applied to list its stock on NASDAQ on April 26, it took slightly more than two weeks for the Canadian cannabis producer to get approved and another week for it to start trading on May 21.OrganiGram produces indoor-grown medical and adult-use cannabis in Canada and has distribution across all 10 provinces. The company’s plants for recreational use have recently received organic certification from the Pro-Cert Organic Systems Ltd. In anticipation of the legalization of edibles in Canada later this year, OrganiGram has invested $15 million into an automated production line for cannabis-infused chocolate that has a capacity of 4.0 million kilograms per year, which will be delivered this fall.Pyxus International Inc (NYSE:PYX)DelistedUntil recently, Pyxus International was known as Alliance One International and was involved in tobacco growing and packaging. Earlier this year, the company rebranded into Pyxus as it embraced cannabis. In January, Pyxus’s subsidiary Canadian Cultivated Products acquired 75 percent of Canada’s Island Garden and 80 percent of Goldleaf Pharm. Later, Canadian Cultivated Products was rebranded into FIGR Cannabis.At the beginning of October, Goldleaf received a cultivation license from Health Canada. In addition, Canada’s Island Garden has received a license to sell marijuana and signed an agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products. Moreover, Pyxus International’s Korent subsidiary is involved in the production of industrial hemp and hemp-derived CBD oil and liquid for e-cigarettes.Sundial Growers Inc. (NASDAQ:SNDL)Alberta-based cannabis company, Sundial Growers is known for cultivating a specific range of cannabis strains. It has established cannabis brands to Heal, Help and Play, with Heal symbolizing cannabis products consumed as prescribed medical therapies, Help products that support overall health and wellbeing via CBD, and Play that includes products for empowering social and spiritual occasions. The company runs two locations in Alberta, but it has announced plans to expand to British Columbia by building a new facility.Therapix Biosciences Ltd (NASDAQ:TRPX)DelistedIsrael-based Therapix Biosciences is involved in developing a pipeline of drugs based on the FDA-approved cannabinoid Dronabinol, such as THX-110 for the treatment of Tourette syndrome and obstructive sleep apnea, THX-130 for mild cognitive impairments and THX-150 for the treatment of infectious diseases. Recently, Canadian marijuana producerFSD Pharma(OTC:FSDDF) announced that it would acquire Therapix Biosciences for $48 million in stock.Tilray Inc (NASDAQ:TLRY)In July 2018, Tilray became the first pure-play cannabis company to list on NASDAQ, and its stock quickly captured attention as it surged eightfold in just two months after the IPO.The company was founded in 2013, and in 2016 it became the first medical marijuana producer in North America to receive a good manufacturing practices certification. Tilray’s production capacity currently lags behind giants like Aurora or Canopy Growth at around 15,000 kilograms. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year.Urban-gro, Inc. (NASDAQ:UGRO)An engineering company, urban-gro is primarily focused on the popular horticulture market. It offers integration and design services of advanced environmental equipment systems into high-performance facilities. It has already operated in hundreds of Controlled Environment Agriculture (CEA) facilities.With its crop-agnostic solutions, it reaches the cannabis CEA sphere. The company provides “turn-key commercial cannabis grow room design services and solutions” to help its clients attain their goals working in sync with the environment, plants, and people.  Cannabis grow room designs can be carefully crafted to meet various regulatory demands, including energy efficiency goals, Good Agricultural Practices, and/or Good Manufacturing Practice certification.It also offers its gro-care managed services platform that aims to help with facility optimization.  With its services, urban-gro pushes building performances to another level.Village Farms International, Inc.  (NASDAQ:VFF)Village Farms International is a vertically integrated greenhouse grower and the only publicly traded greenhouse business in Canada. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. The company is connected to the cannabis industry via its majority ownership position in Pure Sunfarms, a Canada-based cannabis growing operations. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U.S hemp-derived CBD market, already having two joint ventures – Village Fields Hemp USA, LLC and Arkansas Valley Green and Gold Hemp LLC.Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)Zynerba Pharmaceuticals is focused on developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric diseases. Among its product candidates is ZYN002 CBD for children and adolescents with Fragile X syndrome, a genetic condition that causes intellectual disability, behavioral and learning challenges and is the most commonly known single-gene cause of autism spectrum disorder. Other targeted conditions include developmental and epileptic encephalopathies and adult epilepsy.Non-Cannabis Companies With Interests In The SpaceAbbVie, Inc. (NYSE:ABBV)This biopharmaceutical company works on creating solutions to help treat various health conditions, from those life-threatening diseases to other chronic disorders. Its core focus is on four therapeutic fields – oncology, neurosciences, virology, and immunology. Its main connection to the cannabis industry lies in its drug, called Marinol, or Dronabinol, which is created of a synthetic form of marijuana. Marinol is used to help with nausea and vomiting caused by chemotherapy, and also to treat the loss of appetite in patients suffering from AIDS.Altria Group, Inc. (NYSE:MO)Altria Group is known as one of the biggest manufacturers and advertisers of tobacco, cigarettes and similar products in the world. While it runs its operations across the world, its main headquarters are located in Virgina, outside of the city of Richmond. Its connection to the cannabis sector is through its considerable stake in a Canada-based pure-play cannabis stock Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).Scotts Miracle-Gro Company (NYSE:SMG)This is a company that produces and sells consumer lawn, garden and pest control products, but some websites consider it a cannabis stock, only because its products can be used in the cannabis industry. In its 2019 Annual Report, the company also states under the ‘risks’ section that end user may buy their products to cultivate cannabis. “Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end-users who may grow any variety of plants, including cannabis.”Psychemedics Corporation (NASDAQ:PMD)This is a provider of hair testing services for the detection of drugs of abuse, offering marijuana hair drug tests as well.","news_type":1},"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135355917,"gmtCreate":1622135124739,"gmtModify":1634183526954,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/135355917","repostId":"2138173935","repostType":4,"repost":{"id":"2138173935","pubTimestamp":1622127610,"share":"https://www.laohu8.com/m/news/2138173935?lang=&edition=full","pubTime":"2021-05-27 23:00","market":"us","language":"en","title":"Snowflake Falls as Investors Weigh Higher Expenses Against Improved Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2138173935","media":"Investing.com","summary":"Investing – Snowflake Inc (NYSE:SNOW) shares fell more than nearly 6% Thursday as more than doubling","content":"<p>Investing – <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a>&nbsp;Inc (NYSE:SNOW) shares fell more than nearly 6% Thursday as more than doubling of losses in the first quarter outweighed the company’s higher guidance for this year.</p><p>A surge in operating expenses, particularly trebling of research and development spending, drove the loss higher to $203.22 million in the 2022 fiscal first quarter ended April 30. The loss in the first quarter of fiscal 2021 was $93.64 million.</p><p>Revenue rose 110% year-on-year to $229 million on new customer acquisitions. &nbsp;The company had 4,532 customers at the end of April compared to 2,720 at the end of same month last year.</p><p>The data-analytics software company managed to more than double the number of its $1 million-plus customers. Their number was 104, up from 48 last April.</p><p>For the full fiscal, Snowflake pegged its forecast for product revenue in the range of $1.02 billion, to $1.03 billion, which means an 86% growth at midpoint.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Falls as Investors Weigh Higher Expenses Against Improved Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Falls as Investors Weigh Higher Expenses Against Improved Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-27 23:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/snowflake-falls-investors-weigh-higher-100610779.html><strong>Investing.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing – Snowflake Inc (NYSE:SNOW) shares fell more than nearly 6% Thursday as more than doubling of losses in the first quarter outweighed the company’s higher guidance for this year.A surge in ...</p>\n\n<a href=\"https://finance.yahoo.com/news/snowflake-falls-investors-weigh-higher-100610779.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"source_url":"https://finance.yahoo.com/news/snowflake-falls-investors-weigh-higher-100610779.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2138173935","content_text":"Investing – Snowflake Inc (NYSE:SNOW) shares fell more than nearly 6% Thursday as more than doubling of losses in the first quarter outweighed the company’s higher guidance for this year.A surge in operating expenses, particularly trebling of research and development spending, drove the loss higher to $203.22 million in the 2022 fiscal first quarter ended April 30. The loss in the first quarter of fiscal 2021 was $93.64 million.Revenue rose 110% year-on-year to $229 million on new customer acquisitions.  The company had 4,532 customers at the end of April compared to 2,720 at the end of same month last year.The data-analytics software company managed to more than double the number of its $1 million-plus customers. Their number was 104, up from 48 last April.For the full fiscal, Snowflake pegged its forecast for product revenue in the range of $1.02 billion, to $1.03 billion, which means an 86% growth at midpoint.","news_type":1},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":135355886,"gmtCreate":1622135151045,"gmtModify":1634183526830,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/135355886","repostId":"1175049399","repostType":4,"repost":{"id":"1175049399","pubTimestamp":1622127032,"share":"https://www.laohu8.com/m/news/1175049399?lang=&edition=full","pubTime":"2021-05-27 22:50","market":"us","language":"en","title":"A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=1175049399","media":"benzinga","summary":"As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a maj","content":"<p>As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.</p><p>Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.</p><p>Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.</p><p>Even though listing on a major exchange such as the NYSE and NASDAQ requires a company to comply with strict transparency and accountability rules, it also sends investors a sign that the company is serious about its business.</p><p>Benzinga has compiled a list of NYSE- and NASDAQ-listed cannabis companies, as well as a short description of the company's involvement in the sector. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business.</p><p>22nd Century Group, Inc. (NYSE:XXII)</p><p>This plant biotechnology company is mostly known for its workings in the tobacco industry, more precisely for its efforts to make smoking less unhealthy by minimizing the levels of nicotine in the tobacco plant. The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine.</p><p>22nd Century Group entered the cannabis space for the first time back in 2014 via a research collaboration with Anandia Labs, obtaining in that manner the U.S. right from Anandia to core patents covering the cannabinoid biosynthetic pathway in hemp/cannabis plants. Furthermore, the company got access to many new hemp-cannabis plant lines such as those with no THC, and those with higher levels of CBD or CBG, which are still part of its plant development pipeline. 22nd Century Group works on developing new hemp/cannabis plants with optimized and unique cannabinoid profiles and advantageous agronomic features.</p><p>The company said its most valuable current partnership covering the hemp/cannabis industry is with KeyGene, an<i>AgBiotech company</i>with a specialty in crop enhancement by molecular breeding.</p><p>Akerna Corp (NASDAQ:KERN)</p><p>Akerna was launched on June 17, 2019, following the merger of cannabis-focused blank check company MTech Acquisition Corp and MJ Freeway, a provider of seed-to-sale regulatory compliance technology and Enterprise Resource Planning platform.</p><p>Akerna is the first cannabis compliance technology company to be traded on NASDAQ and is the first NASDAQ-listed cannabis company led by a woman. The company allows cannabis businesses to connect data points in their supply chain making it more transparent and accountable.</p><p><b>Amyris (NASDAQ:AMRS)</b></p><p>Amyris is a science and technology company that creates and manufactures sustainable ingredients for various markets, such as Clean Health &amp; Beauty, and Flavors &amp; Fragrances. Its connection to the cannabis industry is through the research and production of biosynthetic cannabinoids, including CBG.</p><p><i>(*Note – the company hasinked a dealwith the biotech startup Lavvan to research and develop synthetic cannabinoids in 2019. Last September, Lavvansued the companyfor “wrongful use of Lavvan intellectual property in connection with their development, testing, and production of biosynthetic cannabinoids, including CBG.”)</i></p><p><b>Aphria Inc (NYSE:APHA)</b></p><p>Canadian medical marijuana producer Aphria became the first pure-play cannabis company to trade on the NYSE. The stock debuted on the major exchange on Nov. 2, 2018.</p><p>Prior to that, Aphria's stock had been listed on the over-the-counter market in the U.S. and on the Toronto Stock Exchange. Listing on the NYSE was a major step for Aphria, opening the company to a larger pool of investors.</p><p><b>Applied DNA Sciences Inc. (NASDAQ:APDN)</b></p><p>Applied DNA Sciences is a biotechnology company that provides molecular technologies that promote supply chain security, anti-counterfeiting and anti-theft technology. Last year, the companyentered a $5 million agreementwith a Canadian cannabis consultancy TheraCann International Benchmark to use the company’s “molecular tagging” technology in the cannabis industry. Last year, at an international cannabis conference in Panama, Applied DNA presented its new marijuana tracking technology.</p><p>Arena Pharmaceuticals (NASDAQ:ARNA)</p><p>Arena Pharmaceuticals is a biotech company located in San Diego, which has one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Other parts of its drug pipeline are focused on non-cannabinoid drugs. The core of its cannabis biotech operations is the research and development of its investigational drug candidate called Olorinab (APD371)<i>.</i>This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses.</p><p>Aurora Cannabis Inc (NYSE:ACB)</p><p>Canadian marijuana producer Aurora Cannabis is considered one of the best stocks for full exposure to the cannabis industry. Aurora is one of the largest cannabis companies in the world. It operates eight licensed production facilities, with&nbsp;five sales licenses and operations in 18 countries. The company has a funded production capacity of over 500,000 kilograms. Aurora recently acquired MedReleaf in a $2.5-billion merger, the industry’s largest.</p><p>Canopy Growth Corp (NYSE:CGC)</p><p>Canopy Growth is the largest marijuana company in the world by market capitalization. It’s also one of&nbsp;the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. It started the year with&nbsp;around 800,000 square feet, but recently it has said it reached a licensed platform of 4.3 million feet. Overall, Canopy has a production platform of 5.6 million feet, of which now 75 percent&nbsp;is licensed.</p><p>CannTrust Holdings Inc. (NYSE:CTST)</p><p><i><b>Delisted</b></i></p><p>On Feb. 25, CannTrust Holdings joined its peers on the New York Stock Exchange. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet. CannTrust has a 60,000 square-foot packaging facility in Vaughan, Ontario. Outside of Canada, CannTrust works with Cannatrek Ltd in Australia and has a joint venture with STENOCARE in Denmark.</p><p>Cara Therapeutics (NASDAQ:CARA)</p><p>Clinical-stage biotechnology company, Cara Therapeutics, is involved in the research and design of various chemical entities to help treat pain and itching, with most of them created to address opioid receptors. In previous years the company was examining the potential of CR-701, a synthetic cannabinoid receptor agonist for treating neuropathic pain and its ability to minimize hyperalgesia and allodynia.</p><p>cbdMD Inc (NYSE:YCBD)</p><p>cbdMD offers a range of CBD products, such as tinctures, oil, gummies, topicals and pet products. Recently, the company has partnered with a number of athletes, such as retired UFC champion Quinton “Rampage” Jackson and professional golfer Bubba Watson.</p><p>On May 1, cbdMD changed its name from Level Brands and the ticker from LEVB to YCBD following a vote from shareholders. It's the only CBD-focused U.S. company traded on a major exchange.</p><p><b>Coffee Holding Co., Inc. (NASDAQ:JVA)</b></p><p>A family-run coffee business that has been operating since 1971, providing a plethora of coffee products across the U.S. and Canada, Coffee Holdings joined the cannabis industry this year. In October, the companysigned binding agreementsto attain a 49% ownership of The Jordre Well, LLC, a cannabidiol beverage company, run by founders of Cannuka, a popular CBD skin brand. Under the deal, The Jordre Well will help Coffee Holding in the creation and commercialization of CBD-infused line extensions for the current coffee brands in the company’s portfolio.</p><p><b>Compass Diversified Holdings (NYSE</b>:CODI)</p><p>Compass Diversified Holdings is an investment and holdings company, concentrated on North American middle-market enterprises. It is run by Compass Group Management LLC, which has more than 20 years of experience in the field. Its interest in the cannabis industry is seen through its holdings of Manitoba Harvest and Hemp Oil Canada.</p><p>Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)</p><p>Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company concentrated on the development of new drugs to help with inflammatory and fibrotic illnessesby targeting the endocannabinoid system.Its principal drug candidate is called Lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. Furthermore, the company is working on creating a pipeline of drug candidates that address the endocannabinoid system.</p><p>Cronos Group Inc (NASDAQ:CRON)</p><p>In February, Cronos Group became the first pure-play cannabis stock to list on a major U.S. exchange. Based in Canada, Cronos is a vertically&nbsp;integrated cannabis company whose core business is medical marijuana, but it is also involved in the recreational space following the full legalization of weed in Canada earlier this month. Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. In addition, Cronos owns Peace Naturals and Original BC, which are licensed to grow and sell medical marijuana in Ontario and British Columbia, respectively.</p><p><b>Eastside Distilling, Inc. (NASDAQ:EAST)</b></p><p>Eastside Distilling, Inc. is a producer of award-winning craft spirits in Portland, Oregon, operating for 12 years. It is known for its specially designed product portfolio containing Burnside Bourbon, West End American Whiskey, Portland Potato Vodka, andHue-Hue Coffee Rum, among others.It is linked to the cannabis space through its ownership of Outlandish Beverages LLC, which manufactures and sells CBD-infused non-alcohol beverages.</p><p><b>Evogene (NASDAQ:EVGN)</b>Evogene is a Rehovot, Israel–headquartered computational biology company. It's also listed on Isreal’s Tel Aviv Stock Exchange under the ticker symbol “EVGN.”The company is involved in the creation of new products for life-science-based industries such as human health, agriculture and industrial applications. It has created a Computational Predictive Biology (CPB)&nbsp;platform, which enables computational design of microbes, small molecules and genes as key elements for life-science products. Its several subsidiaries rely on this platform for the development of various products, including medical cannabis (Canonic Ltd – subsidiary).FSD Pharma Inc. (NASDAQ:HUGE)</p><p>FSD Pharma is a biotech pharmaceutical research and development company that works on a pipeline of FDA-approved synthetic compounds directed at affecting the endocannabinoid system to help with various disorders of the central nervous system and autoimmune illnesses of the GI tract, skin, and the musculoskeletal system. Its subsidiary, FV Pharma, is a licensed producer under Canada’s Cannabis Act regulations with the license to grow cannabis in its facility in Cobourg, Ontario.</p><p>Greenlane Holdings, Inc. (NASDAQ:GNLN)</p><p>Greenlane went public on April 18. It's a Florida-based company that distributes over 140 brands of vaporizers and smoking accessories across the world through dispensaries, smoke shops, as well as through its e-commerce platforms.</p><p>The company doesn't provide any cannabis products, but it has major exposure to the industry and is betting big on its growth. Greenlane’s products are distributed across hundreds of licensed cannabis cultivators, processors&nbsp;and dispensaries.</p><p><b>GrowGeneration Corp. (NASDAQ:GRWG)</b></p><p>GroGeneration Corp. is a Denver-based hydroponics innovator and a distributor of agricultural products that also serves U.S. cannabis companies. It runs retail hydroponic and organic specialty gardening retail stores, providing plant nutrition, advanced lighting technology, and farming soils, among others. GrowGeneration recently announced the completion of its acquisition of California-based GrowBiz, one of the largest hydroponic garden centers in the U.S.6</p><p>GW Pharmaceuticals PLC (NASDAQ:GWPH)</p><p>Among pharmaceutical companies, UK-based GW Pharmaceutical is the closest to being a pure-play cannabis company.</p><p>GW is focused on developing cannabis-based drugs. Its Sativex drug, for the treatment of multiple sclerosis, was the first-ever natural cannabis plant derivative to be approved by regulators in any country, receiving UK approval in 2010. Earlier this year, Epidiolex, for the treatment of epilepsy, became the first cannabis-derived drug to bag FDA approval.</p><p>HEXO Corp (NYSE:HEXO)</p><p>Hexo is a Gatineau, Quebec-based adult-use cannabis company that focuses on innovative, smoke-free and traditional cannabis products. The company was previously known as Hydropothecary Corp, but changed its name to HEXO in August 2018 following the launch of the HEXO brand for the adult-use market (medical products retained the Hydropothecary brand).</p><p>In August 2018, HEXO and<b>Molson Coors Brewing Co</b>(NYSE:TAP)’s Canadian division agreed to form a joint venture (later revealed as Truss) to develop non-alcoholic, cannabis-infused beverages for the Canadian market. HEXO’s stock debuted on the NYSE American on Jan. 23.</p><p>India Globalization Capital, Inc. (NYSEAMERICAN: IGC)</p><p>India Globalization Capital is a Maryland-based company with two lines of operations – infrastructure, and cannabinoid-based products. Its cannabis-based products are designed to help with pain, seizures, post-traumatic stress disorder, and various other ailments.The company offers patent-pending products that provide micro-doses of cannabinoids mixed with other natural components.</p><p>Innovative Industrial Properties Inc (NYSE:IIPR)</p><p>Innovative Industrial Properties is the only publicly traded cannabis-focused Real Estate Investment Trust. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U.S. Among its lessees are PharmaCann (New York and Massachusetts), The Pharm (Arizona), Holistic Industries (Maryland and Massachusetts), Green Peak (Michigan) and Vireo Health (Minnesota, New York, and Pennsylvania).</p><p>Intec Pharma Ltd. (NASDAQ:NTEC)</p><p>Intec Pharma is a biopharmaceutical company that works on creating a variety of therapeutics relying on its proprietary According Pill technology. Among, the company’s product pipeline candidates in clinical development are AP-cannabinoids. They are being examined for helping with various conditions such as cancer pain and opioid-sparing pain, by delivering one or both of the main cannabinoids naturally found in Cannabis sativa, CBD and THC.</p><p><b>Marrone Bio Innovations, Inc. (NASDAQ:MBII)</b></p><p>Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for various markets, such as agriculture and water treatment. The company’s three active ingredients are legalized for use on cannabis crops in California.</p><p><b>Neptune Wellness Solutions Inc.(NASDAQ:NEPT)</b></p><p>Neptune Wellness Solutions Inc. is a diversified wellness company. Through its 9354-7537 Quebec Inc., Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its facility in Quebec. It is known for its proprietary recreational product line that includes High CBD Oil, High CBD Capsules, Classic Hashish, and Legacy Hashish.</p><p>NEWAGE (NASDAQ:NBEV)</p><p>NewAge is a Colorado-based omnichannel company that tries to motivate consumers to “live healthy.” It is the only one-stop shop of healthy beverages, with famous brands such as Nestea, Evian, Búcha Live Kombucha, Illy Coffee, and Volvic. Recently the company has announced that its Noni+CBD product has obtained sales approval by the Japanese Ministry of Health and the Japanese Narcotics Control Division. The company also offers a portfolio of hemp products, such as oils, body creams, and roll-on gels, which has reached Australia and New Zealand.</p><p><b>NIC Inc. (NASDAQ:EGOV)</b></p><p>The Olathe, Kansas-based provider of digital government services, NIC Inc. has reached the cannabis space through the acquisition of Complia, a Denver-based technology platform for regulating cannabis and hemp industries.</p><p><b>OrganiGram Holdings Inc (NASDAQ:OGI)</b></p><p>After announcing it had applied to list its stock on NASDAQ on April 26, it took slightly more than two weeks for the Canadian cannabis producer to get approved and another week for it to start trading on May 21.</p><p>OrganiGram produces indoor-grown medical and adult-use cannabis in Canada and has distribution across all 10 provinces. The company’s plants for recreational use have recently received organic certification from the Pro-Cert Organic Systems Ltd. In anticipation of the legalization of edibles in Canada later this year, OrganiGram has invested $15 million into an automated production line for cannabis-infused chocolate that has a capacity of 4.0 million kilograms per year, which will be delivered this fall.</p><p>Pyxus International Inc (NYSE:PYX)</p><p><b><i>Delisted</i></b></p><p>Until recently, Pyxus International was known as Alliance One International and was involved in tobacco growing and packaging. Earlier this year, the company rebranded into Pyxus as it embraced&nbsp;cannabis. In January, Pyxus’s subsidiary Canadian Cultivated Products acquired 75 percent&nbsp;of Canada’s Island Garden and 80 percent&nbsp;of Goldleaf Pharm. Later, Canadian Cultivated Products was rebranded into FIGR Cannabis.</p><p>At the beginning of October, Goldleaf received a cultivation license from Health Canada. In addition, Canada’s Island Garden has received a license to sell marijuana and signed an agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products. Moreover, Pyxus International’s Korent subsidiary is involved in the production of industrial hemp and hemp-derived CBD oil and liquid for e-cigarettes.</p><p>Sundial Growers Inc. (NASDAQ:SNDL)</p><p>Alberta-based cannabis company, Sundial Growers is known for cultivating a specific range of cannabis strains. It has established cannabis brands to Heal, Help and Play, with Heal symbolizing cannabis products consumed as prescribed medical therapies, Help products that support overall health and wellbeing via CBD, and Play that includes products for empowering social and spiritual occasions. The company runs two locations in Alberta, but it has announced plans to expand to British Columbia by building a new facility.</p><p>Therapix Biosciences Ltd (NASDAQ:TRPX)</p><p><b><i>Delisted</i></b></p><p>Israel-based Therapix Biosciences is involved in developing a pipeline of drugs based on the FDA-approved cannabinoid Dronabinol, such as THX-110 for the treatment of Tourette syndrome and obstructive sleep apnea, THX-130 for mild cognitive impairments&nbsp;and THX-150 for the treatment of infectious diseases. Recently, Canadian marijuana producer<b>FSD Pharma</b>(OTC:FSDDF) announced that it would acquire Therapix Biosciences for $48 million in stock.</p><p>Tilray Inc (NASDAQ:TLRY)</p><p>In July 2018, Tilray became the first pure-play cannabis company to list on NASDAQ, and its stock quickly captured attention as it surged eightfold in just two months after the IPO.</p><p>The company was founded in 2013, and in 2016 it became the first medical marijuana producer in North America to receive a good manufacturing practices certification. Tilray’s production capacity currently lags behind giants like Aurora or Canopy Growth at around 15,000 kilograms. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year.</p><p><b>Urban-gro, Inc.</b>&nbsp;(NASDAQ:UGRO)</p><p>An engineering company, urban-gro is primarily focused on the popular horticulture market. It offers integration and design services of advanced environmental equipment systems into high-performance facilities. It has already operated in hundreds of Controlled Environment Agriculture (CEA)&nbsp;facilities.</p><p>With its crop-agnostic solutions, it reaches the cannabis CEA sphere. The company provides “turn-key commercial cannabis grow room design services and solutions” to help its clients attain their goals working in sync with the environment, plants, and people. &nbsp;Cannabis grow room designs can be carefully crafted to meet various regulatory demands, including energy efficiency goals, Good Agricultural Practices, and/or Good Manufacturing Practice certification.</p><p>It also offers its gro-care managed services platform that aims to help with facility optimization. &nbsp;With its services, urban-gro pushes building performances to another level.</p><p>Village Farms International, Inc.&nbsp; (NASDAQ:VFF)</p><p>Village Farms International is a vertically integrated greenhouse grower and the only publicly traded greenhouse business in Canada. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. The company is connected to the cannabis industry via its majority ownership position in Pure Sunfarms, a Canada-based cannabis growing operations. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U.S hemp-derived CBD market, already having two joint ventures – Village Fields Hemp USA, LLC and Arkansas Valley Green and Gold Hemp LLC.</p><p>Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)</p><p>Zynerba Pharmaceuticals is focused on developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric diseases. Among its product candidates is ZYN002 CBD for children and adolescents with Fragile X syndrome, a genetic condition that causes intellectual disability, behavioral and learning challenges and is the most commonly known single-gene cause of autism spectrum disorder. Other targeted conditions include developmental and epileptic encephalopathies and adult epilepsy.</p><p>Non-Cannabis Companies With Interests In The SpaceAbbVie, Inc. (NYSE:ABBV)</p><p>This biopharmaceutical company works on creating solutions to help treat various health conditions, from those life-threatening diseases to other chronic disorders. Its core focus is on four therapeutic fields – oncology, neurosciences, virology, and immunology. Its main connection to the cannabis industry lies in its drug, called Marinol, or Dronabinol, which is created of a synthetic form of marijuana. Marinol is used to help with nausea and vomiting caused by chemotherapy, and also to treat the loss of appetite in patients suffering from AIDS.</p><p>Altria Group, Inc. (NYSE:MO)</p><p>Altria Group is known as one of the biggest manufacturers and advertisers of tobacco, cigarettes and similar products in the world. While it runs its operations across the world, its main headquarters are located in Virgina, outside of the city of Richmond. Its connection to the cannabis sector is through its considerable stake in a Canada-based pure-play cannabis stock Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).</p><p>Scotts Miracle-Gro Company (NYSE:SMG)</p><p>This is a company that produces and sells consumer lawn, garden and pest control products, but some websites consider it a cannabis stock, only because its products can be used in the cannabis industry. In its 2019 Annual Report, the company also states under the ‘risks’ section that end user may buy their products to cultivate cannabis. “Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end-users who may grow any variety of plants, including cannabis.”</p><p>Psychemedics Corporation (NASDAQ:PMD)</p><p>This is a provider of hair testing services for the detection of drugs of abuse, offering marijuana hair drug tests as well.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Complete List Of NYSE And NASDAQ-Listed Cannabis Companies\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-27 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.Given the ...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/markets/cannabis/21/05/12591805/a-complete-list-of-nyse-and-nasdaq-listed-cannabis-companies-updated","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175049399","content_text":"As thecannabisindustry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.Even though listing on a major exchange such as the NYSE and NASDAQ requires a company to comply with strict transparency and accountability rules, it also sends investors a sign that the company is serious about its business.Benzinga has compiled a list of NYSE- and NASDAQ-listed cannabis companies, as well as a short description of the company's involvement in the sector. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business.22nd Century Group, Inc. (NYSE:XXII)This plant biotechnology company is mostly known for its workings in the tobacco industry, more precisely for its efforts to make smoking less unhealthy by minimizing the levels of nicotine in the tobacco plant. The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine.22nd Century Group entered the cannabis space for the first time back in 2014 via a research collaboration with Anandia Labs, obtaining in that manner the U.S. right from Anandia to core patents covering the cannabinoid biosynthetic pathway in hemp/cannabis plants. Furthermore, the company got access to many new hemp-cannabis plant lines such as those with no THC, and those with higher levels of CBD or CBG, which are still part of its plant development pipeline. 22nd Century Group works on developing new hemp/cannabis plants with optimized and unique cannabinoid profiles and advantageous agronomic features.The company said its most valuable current partnership covering the hemp/cannabis industry is with KeyGene, anAgBiotech companywith a specialty in crop enhancement by molecular breeding.Akerna Corp (NASDAQ:KERN)Akerna was launched on June 17, 2019, following the merger of cannabis-focused blank check company MTech Acquisition Corp and MJ Freeway, a provider of seed-to-sale regulatory compliance technology and Enterprise Resource Planning platform.Akerna is the first cannabis compliance technology company to be traded on NASDAQ and is the first NASDAQ-listed cannabis company led by a woman. The company allows cannabis businesses to connect data points in their supply chain making it more transparent and accountable.Amyris (NASDAQ:AMRS)Amyris is a science and technology company that creates and manufactures sustainable ingredients for various markets, such as Clean Health & Beauty, and Flavors & Fragrances. Its connection to the cannabis industry is through the research and production of biosynthetic cannabinoids, including CBG.(*Note – the company hasinked a dealwith the biotech startup Lavvan to research and develop synthetic cannabinoids in 2019. Last September, Lavvansued the companyfor “wrongful use of Lavvan intellectual property in connection with their development, testing, and production of biosynthetic cannabinoids, including CBG.”)Aphria Inc (NYSE:APHA)Canadian medical marijuana producer Aphria became the first pure-play cannabis company to trade on the NYSE. The stock debuted on the major exchange on Nov. 2, 2018.Prior to that, Aphria's stock had been listed on the over-the-counter market in the U.S. and on the Toronto Stock Exchange. Listing on the NYSE was a major step for Aphria, opening the company to a larger pool of investors.Applied DNA Sciences Inc. (NASDAQ:APDN)Applied DNA Sciences is a biotechnology company that provides molecular technologies that promote supply chain security, anti-counterfeiting and anti-theft technology. Last year, the companyentered a $5 million agreementwith a Canadian cannabis consultancy TheraCann International Benchmark to use the company’s “molecular tagging” technology in the cannabis industry. Last year, at an international cannabis conference in Panama, Applied DNA presented its new marijuana tracking technology.Arena Pharmaceuticals (NASDAQ:ARNA)Arena Pharmaceuticals is a biotech company located in San Diego, which has one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Other parts of its drug pipeline are focused on non-cannabinoid drugs. The core of its cannabis biotech operations is the research and development of its investigational drug candidate called Olorinab (APD371).This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses.Aurora Cannabis Inc (NYSE:ACB)Canadian marijuana producer Aurora Cannabis is considered one of the best stocks for full exposure to the cannabis industry. Aurora is one of the largest cannabis companies in the world. It operates eight licensed production facilities, with five sales licenses and operations in 18 countries. The company has a funded production capacity of over 500,000 kilograms. Aurora recently acquired MedReleaf in a $2.5-billion merger, the industry’s largest.Canopy Growth Corp (NYSE:CGC)Canopy Growth is the largest marijuana company in the world by market capitalization. It’s also one of the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. It started the year with around 800,000 square feet, but recently it has said it reached a licensed platform of 4.3 million feet. Overall, Canopy has a production platform of 5.6 million feet, of which now 75 percent is licensed.CannTrust Holdings Inc. (NYSE:CTST)DelistedOn Feb. 25, CannTrust Holdings joined its peers on the New York Stock Exchange. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet. CannTrust has a 60,000 square-foot packaging facility in Vaughan, Ontario. Outside of Canada, CannTrust works with Cannatrek Ltd in Australia and has a joint venture with STENOCARE in Denmark.Cara Therapeutics (NASDAQ:CARA)Clinical-stage biotechnology company, Cara Therapeutics, is involved in the research and design of various chemical entities to help treat pain and itching, with most of them created to address opioid receptors. In previous years the company was examining the potential of CR-701, a synthetic cannabinoid receptor agonist for treating neuropathic pain and its ability to minimize hyperalgesia and allodynia.cbdMD Inc (NYSE:YCBD)cbdMD offers a range of CBD products, such as tinctures, oil, gummies, topicals and pet products. Recently, the company has partnered with a number of athletes, such as retired UFC champion Quinton “Rampage” Jackson and professional golfer Bubba Watson.On May 1, cbdMD changed its name from Level Brands and the ticker from LEVB to YCBD following a vote from shareholders. It's the only CBD-focused U.S. company traded on a major exchange.Coffee Holding Co., Inc. (NASDAQ:JVA)A family-run coffee business that has been operating since 1971, providing a plethora of coffee products across the U.S. and Canada, Coffee Holdings joined the cannabis industry this year. In October, the companysigned binding agreementsto attain a 49% ownership of The Jordre Well, LLC, a cannabidiol beverage company, run by founders of Cannuka, a popular CBD skin brand. Under the deal, The Jordre Well will help Coffee Holding in the creation and commercialization of CBD-infused line extensions for the current coffee brands in the company’s portfolio.Compass Diversified Holdings (NYSE:CODI)Compass Diversified Holdings is an investment and holdings company, concentrated on North American middle-market enterprises. It is run by Compass Group Management LLC, which has more than 20 years of experience in the field. Its interest in the cannabis industry is seen through its holdings of Manitoba Harvest and Hemp Oil Canada.Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company concentrated on the development of new drugs to help with inflammatory and fibrotic illnessesby targeting the endocannabinoid system.Its principal drug candidate is called Lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. Furthermore, the company is working on creating a pipeline of drug candidates that address the endocannabinoid system.Cronos Group Inc (NASDAQ:CRON)In February, Cronos Group became the first pure-play cannabis stock to list on a major U.S. exchange. Based in Canada, Cronos is a vertically integrated cannabis company whose core business is medical marijuana, but it is also involved in the recreational space following the full legalization of weed in Canada earlier this month. Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. In addition, Cronos owns Peace Naturals and Original BC, which are licensed to grow and sell medical marijuana in Ontario and British Columbia, respectively.Eastside Distilling, Inc. (NASDAQ:EAST)Eastside Distilling, Inc. is a producer of award-winning craft spirits in Portland, Oregon, operating for 12 years. It is known for its specially designed product portfolio containing Burnside Bourbon, West End American Whiskey, Portland Potato Vodka, andHue-Hue Coffee Rum, among others.It is linked to the cannabis space through its ownership of Outlandish Beverages LLC, which manufactures and sells CBD-infused non-alcohol beverages.Evogene (NASDAQ:EVGN)Evogene is a Rehovot, Israel–headquartered computational biology company. It's also listed on Isreal’s Tel Aviv Stock Exchange under the ticker symbol “EVGN.”The company is involved in the creation of new products for life-science-based industries such as human health, agriculture and industrial applications. It has created a Computational Predictive Biology (CPB) platform, which enables computational design of microbes, small molecules and genes as key elements for life-science products. Its several subsidiaries rely on this platform for the development of various products, including medical cannabis (Canonic Ltd – subsidiary).FSD Pharma Inc. (NASDAQ:HUGE)FSD Pharma is a biotech pharmaceutical research and development company that works on a pipeline of FDA-approved synthetic compounds directed at affecting the endocannabinoid system to help with various disorders of the central nervous system and autoimmune illnesses of the GI tract, skin, and the musculoskeletal system. Its subsidiary, FV Pharma, is a licensed producer under Canada’s Cannabis Act regulations with the license to grow cannabis in its facility in Cobourg, Ontario.Greenlane Holdings, Inc. (NASDAQ:GNLN)Greenlane went public on April 18. It's a Florida-based company that distributes over 140 brands of vaporizers and smoking accessories across the world through dispensaries, smoke shops, as well as through its e-commerce platforms.The company doesn't provide any cannabis products, but it has major exposure to the industry and is betting big on its growth. Greenlane’s products are distributed across hundreds of licensed cannabis cultivators, processors and dispensaries.GrowGeneration Corp. (NASDAQ:GRWG)GroGeneration Corp. is a Denver-based hydroponics innovator and a distributor of agricultural products that also serves U.S. cannabis companies. It runs retail hydroponic and organic specialty gardening retail stores, providing plant nutrition, advanced lighting technology, and farming soils, among others. GrowGeneration recently announced the completion of its acquisition of California-based GrowBiz, one of the largest hydroponic garden centers in the U.S.6GW Pharmaceuticals PLC (NASDAQ:GWPH)Among pharmaceutical companies, UK-based GW Pharmaceutical is the closest to being a pure-play cannabis company.GW is focused on developing cannabis-based drugs. Its Sativex drug, for the treatment of multiple sclerosis, was the first-ever natural cannabis plant derivative to be approved by regulators in any country, receiving UK approval in 2010. Earlier this year, Epidiolex, for the treatment of epilepsy, became the first cannabis-derived drug to bag FDA approval.HEXO Corp (NYSE:HEXO)Hexo is a Gatineau, Quebec-based adult-use cannabis company that focuses on innovative, smoke-free and traditional cannabis products. The company was previously known as Hydropothecary Corp, but changed its name to HEXO in August 2018 following the launch of the HEXO brand for the adult-use market (medical products retained the Hydropothecary brand).In August 2018, HEXO andMolson Coors Brewing Co(NYSE:TAP)’s Canadian division agreed to form a joint venture (later revealed as Truss) to develop non-alcoholic, cannabis-infused beverages for the Canadian market. HEXO’s stock debuted on the NYSE American on Jan. 23.India Globalization Capital, Inc. (NYSEAMERICAN: IGC)India Globalization Capital is a Maryland-based company with two lines of operations – infrastructure, and cannabinoid-based products. Its cannabis-based products are designed to help with pain, seizures, post-traumatic stress disorder, and various other ailments.The company offers patent-pending products that provide micro-doses of cannabinoids mixed with other natural components.Innovative Industrial Properties Inc (NYSE:IIPR)Innovative Industrial Properties is the only publicly traded cannabis-focused Real Estate Investment Trust. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U.S. Among its lessees are PharmaCann (New York and Massachusetts), The Pharm (Arizona), Holistic Industries (Maryland and Massachusetts), Green Peak (Michigan) and Vireo Health (Minnesota, New York, and Pennsylvania).Intec Pharma Ltd. (NASDAQ:NTEC)Intec Pharma is a biopharmaceutical company that works on creating a variety of therapeutics relying on its proprietary According Pill technology. Among, the company’s product pipeline candidates in clinical development are AP-cannabinoids. They are being examined for helping with various conditions such as cancer pain and opioid-sparing pain, by delivering one or both of the main cannabinoids naturally found in Cannabis sativa, CBD and THC.Marrone Bio Innovations, Inc. (NASDAQ:MBII)Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for various markets, such as agriculture and water treatment. The company’s three active ingredients are legalized for use on cannabis crops in California.Neptune Wellness Solutions Inc.(NASDAQ:NEPT)Neptune Wellness Solutions Inc. is a diversified wellness company. Through its 9354-7537 Quebec Inc., Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its facility in Quebec. It is known for its proprietary recreational product line that includes High CBD Oil, High CBD Capsules, Classic Hashish, and Legacy Hashish.NEWAGE (NASDAQ:NBEV)NewAge is a Colorado-based omnichannel company that tries to motivate consumers to “live healthy.” It is the only one-stop shop of healthy beverages, with famous brands such as Nestea, Evian, Búcha Live Kombucha, Illy Coffee, and Volvic. Recently the company has announced that its Noni+CBD product has obtained sales approval by the Japanese Ministry of Health and the Japanese Narcotics Control Division. The company also offers a portfolio of hemp products, such as oils, body creams, and roll-on gels, which has reached Australia and New Zealand.NIC Inc. (NASDAQ:EGOV)The Olathe, Kansas-based provider of digital government services, NIC Inc. has reached the cannabis space through the acquisition of Complia, a Denver-based technology platform for regulating cannabis and hemp industries.OrganiGram Holdings Inc (NASDAQ:OGI)After announcing it had applied to list its stock on NASDAQ on April 26, it took slightly more than two weeks for the Canadian cannabis producer to get approved and another week for it to start trading on May 21.OrganiGram produces indoor-grown medical and adult-use cannabis in Canada and has distribution across all 10 provinces. The company’s plants for recreational use have recently received organic certification from the Pro-Cert Organic Systems Ltd. In anticipation of the legalization of edibles in Canada later this year, OrganiGram has invested $15 million into an automated production line for cannabis-infused chocolate that has a capacity of 4.0 million kilograms per year, which will be delivered this fall.Pyxus International Inc (NYSE:PYX)DelistedUntil recently, Pyxus International was known as Alliance One International and was involved in tobacco growing and packaging. Earlier this year, the company rebranded into Pyxus as it embraced cannabis. In January, Pyxus’s subsidiary Canadian Cultivated Products acquired 75 percent of Canada’s Island Garden and 80 percent of Goldleaf Pharm. Later, Canadian Cultivated Products was rebranded into FIGR Cannabis.At the beginning of October, Goldleaf received a cultivation license from Health Canada. In addition, Canada’s Island Garden has received a license to sell marijuana and signed an agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products. Moreover, Pyxus International’s Korent subsidiary is involved in the production of industrial hemp and hemp-derived CBD oil and liquid for e-cigarettes.Sundial Growers Inc. (NASDAQ:SNDL)Alberta-based cannabis company, Sundial Growers is known for cultivating a specific range of cannabis strains. It has established cannabis brands to Heal, Help and Play, with Heal symbolizing cannabis products consumed as prescribed medical therapies, Help products that support overall health and wellbeing via CBD, and Play that includes products for empowering social and spiritual occasions. The company runs two locations in Alberta, but it has announced plans to expand to British Columbia by building a new facility.Therapix Biosciences Ltd (NASDAQ:TRPX)DelistedIsrael-based Therapix Biosciences is involved in developing a pipeline of drugs based on the FDA-approved cannabinoid Dronabinol, such as THX-110 for the treatment of Tourette syndrome and obstructive sleep apnea, THX-130 for mild cognitive impairments and THX-150 for the treatment of infectious diseases. Recently, Canadian marijuana producerFSD Pharma(OTC:FSDDF) announced that it would acquire Therapix Biosciences for $48 million in stock.Tilray Inc (NASDAQ:TLRY)In July 2018, Tilray became the first pure-play cannabis company to list on NASDAQ, and its stock quickly captured attention as it surged eightfold in just two months after the IPO.The company was founded in 2013, and in 2016 it became the first medical marijuana producer in North America to receive a good manufacturing practices certification. Tilray’s production capacity currently lags behind giants like Aurora or Canopy Growth at around 15,000 kilograms. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year.Urban-gro, Inc. (NASDAQ:UGRO)An engineering company, urban-gro is primarily focused on the popular horticulture market. It offers integration and design services of advanced environmental equipment systems into high-performance facilities. It has already operated in hundreds of Controlled Environment Agriculture (CEA) facilities.With its crop-agnostic solutions, it reaches the cannabis CEA sphere. The company provides “turn-key commercial cannabis grow room design services and solutions” to help its clients attain their goals working in sync with the environment, plants, and people.  Cannabis grow room designs can be carefully crafted to meet various regulatory demands, including energy efficiency goals, Good Agricultural Practices, and/or Good Manufacturing Practice certification.It also offers its gro-care managed services platform that aims to help with facility optimization.  With its services, urban-gro pushes building performances to another level.Village Farms International, Inc.  (NASDAQ:VFF)Village Farms International is a vertically integrated greenhouse grower and the only publicly traded greenhouse business in Canada. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. The company is connected to the cannabis industry via its majority ownership position in Pure Sunfarms, a Canada-based cannabis growing operations. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U.S hemp-derived CBD market, already having two joint ventures – Village Fields Hemp USA, LLC and Arkansas Valley Green and Gold Hemp LLC.Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)Zynerba Pharmaceuticals is focused on developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric diseases. Among its product candidates is ZYN002 CBD for children and adolescents with Fragile X syndrome, a genetic condition that causes intellectual disability, behavioral and learning challenges and is the most commonly known single-gene cause of autism spectrum disorder. Other targeted conditions include developmental and epileptic encephalopathies and adult epilepsy.Non-Cannabis Companies With Interests In The SpaceAbbVie, Inc. (NYSE:ABBV)This biopharmaceutical company works on creating solutions to help treat various health conditions, from those life-threatening diseases to other chronic disorders. Its core focus is on four therapeutic fields – oncology, neurosciences, virology, and immunology. Its main connection to the cannabis industry lies in its drug, called Marinol, or Dronabinol, which is created of a synthetic form of marijuana. Marinol is used to help with nausea and vomiting caused by chemotherapy, and also to treat the loss of appetite in patients suffering from AIDS.Altria Group, Inc. (NYSE:MO)Altria Group is known as one of the biggest manufacturers and advertisers of tobacco, cigarettes and similar products in the world. While it runs its operations across the world, its main headquarters are located in Virgina, outside of the city of Richmond. Its connection to the cannabis sector is through its considerable stake in a Canada-based pure-play cannabis stock Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).Scotts Miracle-Gro Company (NYSE:SMG)This is a company that produces and sells consumer lawn, garden and pest control products, but some websites consider it a cannabis stock, only because its products can be used in the cannabis industry. In its 2019 Annual Report, the company also states under the ‘risks’ section that end user may buy their products to cultivate cannabis. “Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end-users who may grow any variety of plants, including cannabis.”Psychemedics Corporation (NASDAQ:PMD)This is a provider of hair testing services for the detection of drugs of abuse, offering marijuana hair drug tests as well.","news_type":1},"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160365949,"gmtCreate":1623772973681,"gmtModify":1634028472024,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/160365949","repostId":"1123375053","repostType":4,"repost":{"id":"1123375053","pubTimestamp":1623745435,"share":"https://www.laohu8.com/m/news/1123375053?lang=&edition=full","pubTime":"2021-06-15 16:23","market":"us","language":"en","title":"Tesla, MicroStrategy, Riot Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level","url":"https://stock-news.laohu8.com/highlight/detail?id=1123375053","media":"yahoo","summary":"Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level.\n\nBitcoin has seen significant gai","content":"<p>Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level.</p>\n<p><img src=\"https://static.tigerbbs.com/bcb7953764bb128bc18cd601e00a3e92\" tg-width=\"287\" tg-height=\"367\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Bitcoin</b>&nbsp;has seen significant gains today, as well as stocks of companies related to the world's top cryptocurrency following Elon Musk's reassuring tweet indicating that Tesla will accept the leading cryptocurrency again.</p>\n<p><b>What Happened:</b>&nbsp;CoinMarketCapdatasuggests that Bitcoin price grew by over 14.3% from its 24-hour low of $36,000 to a high of nearly $41,000, before settling at its current price of $40,306 at press time.</p>\n<p><img src=\"https://static.tigerbbs.com/87d03c0cede12209e410f4a012c4c59d\" tg-width=\"1070\" tg-height=\"776\"></p>\n<p>According to Paolo Ardoino, CTO of Bitfinex, \"the king of crypto is carrying cryptocurrency markets higher.\"</p>\n<p>\"Meanwhile, Bitcoin’s utility and use cases such as the Lightning Network continue to strengthen and grow. While it is important to always take a long-term view, we’re seeing a quiet optimism return to the market,\" he added.</p>\n<p>Cryptocurrency mining enterprise&nbsp;<b>Riot Blockchain Inc.</b>(NASDAQ:RIOT) shares are up over 20% Monday, beating even Bitcoin's growth over the last 24-hours, with a stock price of $37.25.</p>\n<p><b>Microstrategy</b>(NASDAQ:MSTR)'s stock has been 15% up Monday and was trading at $590 at press time. The company has invested almost all of its revenue into Bitcoin and raising further capital through the issuance of bonds to buy even more.</p>\n<p>Microstrategy recentlyannouncedthat it intended to raise $400 million to buy Bitcoin but thendecidedto raise $500 instead, and the bond offering got oversubscribed to a total of $1.6 billion.</p>\n<p>Lastly,<b>Tesla Inc</b>(NASDAQ:TSLA) has seen its shares rise by 1.28% Monady after&nbsp;Musk's statement.</p>\n<p><img src=\"https://static.tigerbbs.com/90130509ac2ffdd09edf9123136048fa\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p>\n<p>The shares were trading at $618 at press time.</p>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, MicroStrategy, Riot Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, MicroStrategy, Riot Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 16:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tesla-microstrategy-riot-blockchain-stocks-170045555.html><strong>yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level.\n\nBitcoin has seen significant gains today, as well as stocks of companies related to the world's top cryptocurrency following Elon ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tesla-microstrategy-riot-blockchain-stocks-170045555.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAN":"嘉楠科技","MARA":"Marathon Digital Holdings Inc","TSLA":"特斯拉","RIOT":"Riot Platforms"},"source_url":"https://finance.yahoo.com/news/tesla-microstrategy-riot-blockchain-stocks-170045555.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123375053","content_text":"Blockchain Stocks Up As Bitcoin Regains Strength At $40,000 Level.\n\nBitcoin has seen significant gains today, as well as stocks of companies related to the world's top cryptocurrency following Elon Musk's reassuring tweet indicating that Tesla will accept the leading cryptocurrency again.\nWhat Happened: CoinMarketCapdatasuggests that Bitcoin price grew by over 14.3% from its 24-hour low of $36,000 to a high of nearly $41,000, before settling at its current price of $40,306 at press time.\n\nAccording to Paolo Ardoino, CTO of Bitfinex, \"the king of crypto is carrying cryptocurrency markets higher.\"\n\"Meanwhile, Bitcoin’s utility and use cases such as the Lightning Network continue to strengthen and grow. While it is important to always take a long-term view, we’re seeing a quiet optimism return to the market,\" he added.\nCryptocurrency mining enterprise Riot Blockchain Inc.(NASDAQ:RIOT) shares are up over 20% Monday, beating even Bitcoin's growth over the last 24-hours, with a stock price of $37.25.\nMicrostrategy(NASDAQ:MSTR)'s stock has been 15% up Monday and was trading at $590 at press time. The company has invested almost all of its revenue into Bitcoin and raising further capital through the issuance of bonds to buy even more.\nMicrostrategy recentlyannouncedthat it intended to raise $400 million to buy Bitcoin but thendecidedto raise $500 instead, and the bond offering got oversubscribed to a total of $1.6 billion.\nLastly,Tesla Inc(NASDAQ:TSLA) has seen its shares rise by 1.28% Monady after Musk's statement.\n\nThe shares were trading at $618 at press time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115359688,"gmtCreate":1622953042644,"gmtModify":1634096624055,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/115359688","repostId":"2140540596","repostType":4,"repost":{"id":"2140540596","pubTimestamp":1622820692,"share":"https://www.laohu8.com/m/news/2140540596?lang=&edition=full","pubTime":"2021-06-04 23:31","market":"us","language":"en","title":"3 Technology Stocks You Can Buy and Hold for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2140540596","media":"Motley Fool","summary":"It can be tough to get married to stocks -- especially tech -- but here are three to leave alone for the long haul.","content":"<p>Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any profitable trade is technically a good trade. If you can get in and out at the right time, so be it.</p>\n<p>Thing is, there are plenty of tech names that are more than just flash-in-the-pan prospects, and are better suited for holding periods measured in years rather than weeks.</p>\n<p>Here's a closer look at three such technology companies. Not only will they be just as impressive 10 years from now as they are today, but their stocks should be trading at much higher prices.</p>\n<h2>Microsoft</h2>\n<p>It's tough to imagine a world without <b>Microsoft</b> (NASDAQ:MSFT). Its Windows operating system is installed on three-fourths of the world's desktops and laptops, according to GlobalStats, and its Office productivity software remains the gold standard for the category. <b>Sony</b>'s PlayStation gaming console enjoys more worldwide market share than Microsoft's Xbox, but the Xbox is closing the gap, and is still the most popular game console in the U.S.</p>\n<p>And these are things consumers can readily see. There's a whole different unseen array of Microsoft-made products that are doing similarly well. For instance, Canalys reports Microsoft's cloud computing business accounted for a second-best 19% of the world's first-quarter cloud infrastructure spending, and the company continues to close the gap with market-leader <b>Amazon</b>.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/362a8a5cb8d412d4e3895fa185d236b7\" tg-width=\"700\" tg-height=\"484\"><span>Image source: Getty Images.</span></p>\n<p>Now take a step back and ask a thoughtful, critical question: Is there any chance the world will have less need for computers, cloud computing, productivity software, or game consoles 10 years from now?</p>\n<p>Any reasonable and realistic answer has to be \"no.\" Indeed, it would be surprising if demand for these products and services wasn't considerably greater a decade from now. Being a market leader in multiple categories, Microsoft can steer the market's ongoing growth in a way that serves itself best. For example, the Windows operating system comes with trial versions of Office software pre-installed.</p>\n<p>Bolstering the bullish argument for long-term ownership of Microsoft is the company's evolving business model. Access to Azure, Office, and even video games can now be utilized on a monthly subscription basis, accessible via the cloud. This shift not only makes the company's products more affordable to begin using but also gives Microsoft a better chance of keeping those customers by making it easy to update and upgrade software.</p>\n<p>Last year, the last time Microsoft disclosed such data, it had already lined up more than $100 billion worth of subscription cloud revenue that had yet to be booked -- a figure that continues to edge upward.</p>\n<h2><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></h2>\n<p>Even after several high-profile cybersecurity gaffes embarrassed organizations ranging from <b>Target </b>to <b>Equifax</b> to Yahoo!, some of the world's most important companies are still being hacked. Most recently, Colonial Pipeline agreed to fork over $4.4 million to a computer hacking group known as Darkside to regain control of its 5,500 miles worth of refined oil pipelines.</p>\n<p>These things are preventable. They're just not being prevented, as too many organizations don't utilize all the digital defenses available to them. Perhaps the Colonial Pipeline debacle will encourage procurement of this protection.</p>\n<p>Enter <b>Palo Alto Networks</b> (NYSE:PANW). Simply put, Palo Alto offers software preventing unauthorized access to a company's network, internal apps, and data. It's even got a ransomware protection solution in its lineup that might have been able to save Colonial Pipeline a few million bucks.</p>\n<p>The opportunity is incredible, and should remain so for a while. P&amp;S Intelligence believes the cybersecurity market will grow at an average annual pace of 12.6%, from 2019's $120 billion to $434 billion by 2030. That's a lot, but it's only a fraction of the $10.5 trillion that Cybersecurity Ventures believes cybercrime will cost the world in 2025 alone if enterprises don't step up their digital defense games.</p>\n<p>Palo Alto is doing fine, logging more than seven consecutive years of rising revenue as more and more outfits build their digital moats. Given the outlook, more of the same kind of growth is in the cards for a while.</p>\n<h2>International Business Machines</h2>\n<p>Finally, add <b>International Business Machines</b> (NYSE:IBM) to your list of technology stocks to buy and hold for the next decade.</p>\n<p>Yes, this is the same IBM that failed to respond to the advent of things like cloud computing, mobile devices, and all that goes with both. The company's \"strategic imperatives\" plan unveiled in 2015 was meant to steer the company away from a legacy mainframe business that was already dying and toward more contemporary opportunities like the aforementioned cloud and mobile security. By and large, though, it was too little too late.</p>\n<p>The IBM of today, however, isn't the IBM from even as recently as two years ago. It's ready to compete where it counts.</p>\n<p>Take last month's revelation of new technologies capable of fabricating a 2-nanometer microchip as an example. The microscopic measure is in reference to how small a chip's transistors can be made and still function properly. The smaller, the better, as smaller transistors consume less power, operate faster, and require less space when room is a factor. For perspective, 7-nanometer chips are the best the market has to offer right now.</p>\n<p>It's not just more functional chips IBM is starting to develop, either. Just within the past few weeks, the company has unveiled a way for data centers to more efficiently store and retrieve data, and launched AutoSQL, which is capable of retrieving data eight times faster than previous approaches are. Both technologies have a myriad of potential uses, including in the artificial intelligence arena.</p>\n<p>Read between the lines. This isn't yesteryear's IBM.</p>\n<p>It could still take years for the company to fully monetize these and other breakthroughs, but they're worth the wait.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Technology Stocks You Can Buy and Hold for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Technology Stocks You Can Buy and Hold for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-04 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软","IBM":"IBM","PANW":"Palo Alto Networks"},"source_url":"https://www.fool.com/investing/2021/06/04/3-technology-stocks-you-can-buy-and-hold-for-the-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2140540596","content_text":"Let's be honest. A lot of people say their positions in flashy technology companies are meant to be long-term holdings, but they're really just an effort to make a quick buck. And that's OK. Any profitable trade is technically a good trade. If you can get in and out at the right time, so be it.\nThing is, there are plenty of tech names that are more than just flash-in-the-pan prospects, and are better suited for holding periods measured in years rather than weeks.\nHere's a closer look at three such technology companies. Not only will they be just as impressive 10 years from now as they are today, but their stocks should be trading at much higher prices.\nMicrosoft\nIt's tough to imagine a world without Microsoft (NASDAQ:MSFT). Its Windows operating system is installed on three-fourths of the world's desktops and laptops, according to GlobalStats, and its Office productivity software remains the gold standard for the category. Sony's PlayStation gaming console enjoys more worldwide market share than Microsoft's Xbox, but the Xbox is closing the gap, and is still the most popular game console in the U.S.\nAnd these are things consumers can readily see. There's a whole different unseen array of Microsoft-made products that are doing similarly well. For instance, Canalys reports Microsoft's cloud computing business accounted for a second-best 19% of the world's first-quarter cloud infrastructure spending, and the company continues to close the gap with market-leader Amazon.\nImage source: Getty Images.\nNow take a step back and ask a thoughtful, critical question: Is there any chance the world will have less need for computers, cloud computing, productivity software, or game consoles 10 years from now?\nAny reasonable and realistic answer has to be \"no.\" Indeed, it would be surprising if demand for these products and services wasn't considerably greater a decade from now. Being a market leader in multiple categories, Microsoft can steer the market's ongoing growth in a way that serves itself best. For example, the Windows operating system comes with trial versions of Office software pre-installed.\nBolstering the bullish argument for long-term ownership of Microsoft is the company's evolving business model. Access to Azure, Office, and even video games can now be utilized on a monthly subscription basis, accessible via the cloud. This shift not only makes the company's products more affordable to begin using but also gives Microsoft a better chance of keeping those customers by making it easy to update and upgrade software.\nLast year, the last time Microsoft disclosed such data, it had already lined up more than $100 billion worth of subscription cloud revenue that had yet to be booked -- a figure that continues to edge upward.\nPalo Alto Networks\nEven after several high-profile cybersecurity gaffes embarrassed organizations ranging from Target to Equifax to Yahoo!, some of the world's most important companies are still being hacked. Most recently, Colonial Pipeline agreed to fork over $4.4 million to a computer hacking group known as Darkside to regain control of its 5,500 miles worth of refined oil pipelines.\nThese things are preventable. They're just not being prevented, as too many organizations don't utilize all the digital defenses available to them. Perhaps the Colonial Pipeline debacle will encourage procurement of this protection.\nEnter Palo Alto Networks (NYSE:PANW). Simply put, Palo Alto offers software preventing unauthorized access to a company's network, internal apps, and data. It's even got a ransomware protection solution in its lineup that might have been able to save Colonial Pipeline a few million bucks.\nThe opportunity is incredible, and should remain so for a while. P&S Intelligence believes the cybersecurity market will grow at an average annual pace of 12.6%, from 2019's $120 billion to $434 billion by 2030. That's a lot, but it's only a fraction of the $10.5 trillion that Cybersecurity Ventures believes cybercrime will cost the world in 2025 alone if enterprises don't step up their digital defense games.\nPalo Alto is doing fine, logging more than seven consecutive years of rising revenue as more and more outfits build their digital moats. Given the outlook, more of the same kind of growth is in the cards for a while.\nInternational Business Machines\nFinally, add International Business Machines (NYSE:IBM) to your list of technology stocks to buy and hold for the next decade.\nYes, this is the same IBM that failed to respond to the advent of things like cloud computing, mobile devices, and all that goes with both. The company's \"strategic imperatives\" plan unveiled in 2015 was meant to steer the company away from a legacy mainframe business that was already dying and toward more contemporary opportunities like the aforementioned cloud and mobile security. By and large, though, it was too little too late.\nThe IBM of today, however, isn't the IBM from even as recently as two years ago. It's ready to compete where it counts.\nTake last month's revelation of new technologies capable of fabricating a 2-nanometer microchip as an example. The microscopic measure is in reference to how small a chip's transistors can be made and still function properly. The smaller, the better, as smaller transistors consume less power, operate faster, and require less space when room is a factor. For perspective, 7-nanometer chips are the best the market has to offer right now.\nIt's not just more functional chips IBM is starting to develop, either. Just within the past few weeks, the company has unveiled a way for data centers to more efficiently store and retrieve data, and launched AutoSQL, which is capable of retrieving data eight times faster than previous approaches are. Both technologies have a myriad of potential uses, including in the artificial intelligence arena.\nRead between the lines. This isn't yesteryear's IBM.\nIt could still take years for the company to fully monetize these and other breakthroughs, but they're worth the wait.","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116257956,"gmtCreate":1622806974075,"gmtModify":1634097838262,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Naise","listText":"Naise","text":"Naise","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116257956","repostId":"1118016370","repostType":4,"repost":{"id":"1118016370","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622729217,"share":"https://www.laohu8.com/m/news/1118016370?lang=&edition=full","pubTime":"2021-06-03 22:06","market":"us","language":"en","title":"Express shares tumble after retailer announces plan to sell 15 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1118016370","media":"Tiger Newspress","summary":"KEY POINTS\n\nShares of the retailer Express tumbled Thursday, after the clothing retailer announced p","content":"<p><b>KEY POINTS</b></p>\n<ul>\n <li>Shares of the retailer Express tumbled Thursday, after the clothing retailer announced plans to sell up to 15 million shares.</li>\n <li>Express announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding.</li>\n <li>Earlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results.</li>\n</ul>\n<p>Shares of the retailer&nbsp;Express&nbsp;tumbled more than 22% Thursday, after the clothing retailer announced plans to sell up to 15 million shares.</p>\n<p><img src=\"https://static.tigerbbs.com/78ae5e3b3840e30951812699b6f5c3d1\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Express announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding. This type of offering means the newly issued stock will be sold from time to time at market prices. Its advantage is that it gives Express control over when it will offer the stock and how much stock it will offer.</p>\n<p>The huge sell-off comes after the stock shot up more than 35% Wednesday, as part of a meme stock trading frenzy that has also boosted shares of&nbsp;AMC Entertainment,GameStop,BlackBerry&nbsp;and&nbsp;Bed Bath &amp; Beyond.</p>\n<p>Express shares had rallied nearly 110% over the past month. The so-called meme stocks, generally shunned by Wall Street, are being cheered by retail investors on online forums like Reddit’s WallStreetBets.</p>\n<p>MKM Partners Managing Director Roxanne Meyer told clients that daily trading volumes of Express shares are still well above historic levels, fueled by Reddit speculation.</p>\n<p>Earlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results. It said its business hit an inflection point after Easter, as more consumers were vaccinated and states began lifting Covid-related restrictions. It also saw people return to its stores buying occasion-based and work-related apparel merchandise.</p>\n<p>Express said in the release announcing its equity offering that it plans to use the net proceeds from its stock sale for general corporate purposes, which could include repaying debts or investing in e-commerce.</p>\n<p>Last year, in the thick of the Covid pandemic, Express was on many analysts’ watch lists as a retailer that could be heading for bankruptcy. But the company managed to come up with additional financing, outside of a court restructuring, to keep its business afloat and outlast the health crisis.</p>\n<p>AMC also said Thursday it plans to sell more than 11 million shares, sending shares of the movie theater chain tumbling.</p>\n<p><img src=\"https://static.tigerbbs.com/7636dfd3d2ab9485e222cf7de79b6934\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Shares of Express are up more than 615% year to date.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Express shares tumble after retailer announces plan to sell 15 million shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExpress shares tumble after retailer announces plan to sell 15 million shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-03 22:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>KEY POINTS</b></p>\n<ul>\n <li>Shares of the retailer Express tumbled Thursday, after the clothing retailer announced plans to sell up to 15 million shares.</li>\n <li>Express announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding.</li>\n <li>Earlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results.</li>\n</ul>\n<p>Shares of the retailer&nbsp;Express&nbsp;tumbled more than 22% Thursday, after the clothing retailer announced plans to sell up to 15 million shares.</p>\n<p><img src=\"https://static.tigerbbs.com/78ae5e3b3840e30951812699b6f5c3d1\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Express announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding. This type of offering means the newly issued stock will be sold from time to time at market prices. Its advantage is that it gives Express control over when it will offer the stock and how much stock it will offer.</p>\n<p>The huge sell-off comes after the stock shot up more than 35% Wednesday, as part of a meme stock trading frenzy that has also boosted shares of&nbsp;AMC Entertainment,GameStop,BlackBerry&nbsp;and&nbsp;Bed Bath &amp; Beyond.</p>\n<p>Express shares had rallied nearly 110% over the past month. The so-called meme stocks, generally shunned by Wall Street, are being cheered by retail investors on online forums like Reddit’s WallStreetBets.</p>\n<p>MKM Partners Managing Director Roxanne Meyer told clients that daily trading volumes of Express shares are still well above historic levels, fueled by Reddit speculation.</p>\n<p>Earlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results. It said its business hit an inflection point after Easter, as more consumers were vaccinated and states began lifting Covid-related restrictions. It also saw people return to its stores buying occasion-based and work-related apparel merchandise.</p>\n<p>Express said in the release announcing its equity offering that it plans to use the net proceeds from its stock sale for general corporate purposes, which could include repaying debts or investing in e-commerce.</p>\n<p>Last year, in the thick of the Covid pandemic, Express was on many analysts’ watch lists as a retailer that could be heading for bankruptcy. But the company managed to come up with additional financing, outside of a court restructuring, to keep its business afloat and outlast the health crisis.</p>\n<p>AMC also said Thursday it plans to sell more than 11 million shares, sending shares of the movie theater chain tumbling.</p>\n<p><img src=\"https://static.tigerbbs.com/7636dfd3d2ab9485e222cf7de79b6934\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Shares of Express are up more than 615% year to date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","EXPR":"Express, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118016370","content_text":"KEY POINTS\n\nShares of the retailer Express tumbled Thursday, after the clothing retailer announced plans to sell up to 15 million shares.\nExpress announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding.\nEarlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results.\n\nShares of the retailer Express tumbled more than 22% Thursday, after the clothing retailer announced plans to sell up to 15 million shares.\n\nExpress announced an “at-the-market” equity offering, which could represent more than 22% of its shares outstanding. This type of offering means the newly issued stock will be sold from time to time at market prices. Its advantage is that it gives Express control over when it will offer the stock and how much stock it will offer.\nThe huge sell-off comes after the stock shot up more than 35% Wednesday, as part of a meme stock trading frenzy that has also boosted shares of AMC Entertainment,GameStop,BlackBerry and Bed Bath & Beyond.\nExpress shares had rallied nearly 110% over the past month. The so-called meme stocks, generally shunned by Wall Street, are being cheered by retail investors on online forums like Reddit’s WallStreetBets.\nMKM Partners Managing Director Roxanne Meyer told clients that daily trading volumes of Express shares are still well above historic levels, fueled by Reddit speculation.\nEarlier Thursday morning, Express’ stock had jumped after the retailer reported better-than-expected fiscal first-quarter results. It said its business hit an inflection point after Easter, as more consumers were vaccinated and states began lifting Covid-related restrictions. It also saw people return to its stores buying occasion-based and work-related apparel merchandise.\nExpress said in the release announcing its equity offering that it plans to use the net proceeds from its stock sale for general corporate purposes, which could include repaying debts or investing in e-commerce.\nLast year, in the thick of the Covid pandemic, Express was on many analysts’ watch lists as a retailer that could be heading for bankruptcy. But the company managed to come up with additional financing, outside of a court restructuring, to keep its business afloat and outlast the health crisis.\nAMC also said Thursday it plans to sell more than 11 million shares, sending shares of the movie theater chain tumbling.\n\nShares of Express are up more than 615% year to date.","news_type":1},"isVote":1,"tweetType":1,"viewCount":365,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111185447,"gmtCreate":1622662677889,"gmtModify":1634099456961,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"to the moon!","listText":"to the moon!","text":"to the moon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/111185447","repostId":"1135947847","repostType":4,"repost":{"id":"1135947847","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622548103,"share":"https://www.laohu8.com/m/news/1135947847?lang=&edition=full","pubTime":"2021-06-01 19:48","market":"us","language":"en","title":"AMC stock rose to as high as $30.41 in premarket trading, up 16.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135947847","media":"Tiger Newspress","summary":"AMC Entertainment stock rose to as high as $30.41 in premarket trading, up 16.42%.AMC sells 8.5 mill","content":"<p>AMC Entertainment&nbsp;stock&nbsp;rose&nbsp;to&nbsp;as high as $30.41 in premarket trading, up&nbsp;16.42%.AMC sells 8.5 million shares at near 4% premium to Mudrick Capital.</p><p><img src=\"https://static.tigerbbs.com/92dcbb37932718d711dfd6cef79469bf\" tg-width=\"924\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p>AMC Entertainment Holdings Inc.&nbsp;disclosed Tuesday that it sold 8.5 million shares of its common stock for $230.5 million to Mudrick Capital Management L.P. The share sale deal would represent a price of for AMC's stock of $27.12 a share, which is 3.8% above Friday's closing price of $26.12. The movie theater operator's stock jumped more&nbsp;than&nbsp;16% in premarket trading, after rocketing 116.2% last week. AMC said it plans to use the proceeds for \"the pursuit of value creating acquisitions of theatre assets and leases, as well as investments to enhance the consumer appeal of its theatres.\" AMC said it will also look for opportunities to reduce debt. The sale of shares represents 1.9% of the 450.3 million shares outstanding as of May 2. AMC's stock, which closed Thursday at a four-year high, has skyrocketed 1,132.1% year to date through Friday, while shares of fellow meme stock GameStop Corp.&nbsp;has soared 1,078.3% and the S&amp;P 500 has climbed 11.9%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC stock rose to as high as $30.41 in premarket trading, up 16.42%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC stock rose to as high as $30.41 in premarket trading, up 16.42%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-01 19:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AMC Entertainment&nbsp;stock&nbsp;rose&nbsp;to&nbsp;as high as $30.41 in premarket trading, up&nbsp;16.42%.AMC sells 8.5 million shares at near 4% premium to Mudrick Capital.</p><p><img src=\"https://static.tigerbbs.com/92dcbb37932718d711dfd6cef79469bf\" tg-width=\"924\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p>AMC Entertainment Holdings Inc.&nbsp;disclosed Tuesday that it sold 8.5 million shares of its common stock for $230.5 million to Mudrick Capital Management L.P. The share sale deal would represent a price of for AMC's stock of $27.12 a share, which is 3.8% above Friday's closing price of $26.12. The movie theater operator's stock jumped more&nbsp;than&nbsp;16% in premarket trading, after rocketing 116.2% last week. AMC said it plans to use the proceeds for \"the pursuit of value creating acquisitions of theatre assets and leases, as well as investments to enhance the consumer appeal of its theatres.\" AMC said it will also look for opportunities to reduce debt. The sale of shares represents 1.9% of the 450.3 million shares outstanding as of May 2. AMC's stock, which closed Thursday at a four-year high, has skyrocketed 1,132.1% year to date through Friday, while shares of fellow meme stock GameStop Corp.&nbsp;has soared 1,078.3% and the S&amp;P 500 has climbed 11.9%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135947847","content_text":"AMC Entertainment stock rose to as high as $30.41 in premarket trading, up 16.42%.AMC sells 8.5 million shares at near 4% premium to Mudrick Capital.AMC Entertainment Holdings Inc. disclosed Tuesday that it sold 8.5 million shares of its common stock for $230.5 million to Mudrick Capital Management L.P. The share sale deal would represent a price of for AMC's stock of $27.12 a share, which is 3.8% above Friday's closing price of $26.12. The movie theater operator's stock jumped more than 16% in premarket trading, after rocketing 116.2% last week. AMC said it plans to use the proceeds for \"the pursuit of value creating acquisitions of theatre assets and leases, as well as investments to enhance the consumer appeal of its theatres.\" AMC said it will also look for opportunities to reduce debt. The sale of shares represents 1.9% of the 450.3 million shares outstanding as of May 2. AMC's stock, which closed Thursday at a four-year high, has skyrocketed 1,132.1% year to date through Friday, while shares of fellow meme stock GameStop Corp. has soared 1,078.3% and the S&P 500 has climbed 11.9%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135355917,"gmtCreate":1622135124739,"gmtModify":1634183526954,"author":{"id":"3584420887262369","authorId":"3584420887262369","name":"dseol","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584420887262369","authorIdStr":"3584420887262369"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/135355917","repostId":"2138173935","repostType":4,"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}